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Abstract
Identification of the environmental reservoir of Mycobacterium ulcerans, the
etiological agent of Buruli ulcer, within the aquatic ecosystem has been a salient
research area within the last five years. Based on extensive environmental sampling
and elegant laboratory models, associations have been made between the bacterial
DNA and aquatic invertebrates, biofilms, plants, fish and detritus material captured on
0.2µm pore filters. These studies have suggested that M. ulcerans is widely distributed
within many functional feeding groups and may be concentrated through different
trophic links; however, the specific route of transmission to humans remains a
mystery. In this study we have used laboratory models of infection to ascertain the role
of aquatic invertebrates and fish in M. ulcerans transmission. A biologically relevant
infection model in which M. ulcerans-infected mosquito larvae were fed to a species of
predaceous hemiptera (African Belostomatidae) was used to demonstrate the persistent
colonization of M. ulcerans and subsequent transmission of bacteria to naïve prey. The
association of M. ulcerans with specific anatomical compartments showed that M.
ulcerans accumulates preferentially on the exoskeleton. No difference was found
between the ability of wild-type M. ulcerans and an M. ulcerans isogenic
mycolactone-negative mutant to colonize belostomatids. These data show that African
belostomatids can successfully be colonized by M. ulcerans and support the trophic
transfer of M. ulcerans within the environment. We have shown that M. ulcerans with
or without the toxin is not lethal to fish (Medaka) even at high doses following direct
inoculation. Over time (23wks), infected Medaka do not exhibit any visible signs of
infection or toxicity and histopathological sections do not reveal significant gross
pathogenesis. M. ulcerans also appears not to replicate in infected Medaka. We also
show that fish monocytes are susceptible to nanogram amounts of purified
mycolactone. This is the first study to demonstrate the possibility of fish as a reservoir
for M. ulcerans within the aquatic environment.
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Chapter 1: Background and significance
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1.1 Buruli ulcer disease
During the last two decades, there has been a re-emergence of the debilitating skin
disease Buruli ulcer across diverse regions of the world. The disease was named for its
initial onset in the Buruli district in Uganda, Central Africa (10) and is also known as
Bairnsdale ulcer in Australia, where the first clinical case was published (32, 47). Until
recently, much of the public and the medical community were unaware of the disease,
which has now been reported in over 30 countries worldwide (Fig. 1.1). West and Central
Africa, especially, Ghana (3, 4, 9), Cote d’Ivoire (31, 36), Nigeria (39) and Congo (54),
and some parts of Australia are the most affected regions (33, 38, 56). Since 1980,
significant increases in the incidence of the disease have been reported in these areas with
new foci also developing in previously non-endemic countries like Togo (37) and Angola
(7). Other endemic areas of the world include Papua New Guinea (14), Malaysia (41),
Mexico (3) and French Guiana (20).More than 20,000 cases have been reported in West
Africa during the last decade (69).
All age groups are affected by Buruli ulcer, but children under 15 years represent
the largest disease burden (12). There does not appear to be a sex difference in disease
incidence among both adults and children, and this is somewhat puzzling since men and
women have very different roles in the poor rural areas where the disease occurs (12).
Again there might be a bias in case reporting because of the lack of immediate health care
facilities and the preference of treatment by herbalists compared to health centers (65,
66). Buruli ulcer disease is a significant cause of morbidity in affected individuals but
lethal infections are extremely rare.
The disease is focal in nature and has been associated with slow moving and
stagnant water bodies within endemic areas. There may be pockets of cases within the
same geographic area that are endemic for the disease within neighboring areas that do
not have any disease at all. In view of this, the disease burden is difficult to obtain, but it
is has been estimated that 25% of people in West Africa are affected by the disease (28).
Some seasonal variation has been thought to exist with the disease. In Australia for
instance, it was noted that the disease appeared at the end of the autumn or winter (21,
23). In Uganda, two previous studies have reported a peak of incidence in the low rainfall
2

months between May and September (1, 10). In Ghana and Cote d’Ivoire, the disease is at
its highest during the months of September and October, which is also the onset of the
dry season (4, 36). Thus, this seemingly temporal dry period onset of the disease cuts
across geographical boundaries and could be indicative of a potential risk factor.
Common to all these areas is the correlation between disease prevalence and
environmental disturbance, both natural and man made including flooding, sand winning,
deforestation, and urbanization of previously rural areas (28).

1.2 Causative organism and pathology
Buruli ulcer is caused by an environmental member of the Mycobacteria family,
Mycobacterium ulcerans. M. ulcerans is a slow growing bacterium with a generation
time of about 72 hours. It has a restricted growth temperature range of 28°C to 34°C. It
stains acid-fast positive with the Ziehl Neelsen stain and typically tends to grow in
clumps and cords. Molecular analysis shows that M. ulcerans is closely related to M.
marinum, which causes disease in fish. In addition to its chromosome, M. ulcerans has a
174-kilobase plasmid, pMUM001, which produces a virulent macrolide toxin,
mycolactone (17, 58). Mycolactone is composed of an invariant core comprising a 12membered macrolactone that is esterified to a highly unsaturated acyl side chain (26). It
is interesting to note that different congeners of mycolactone are made by the different
geographical isolates and this directly corresponds to their degree of toxicity. The most
potent congener, mycolactone A/B, is made by the African and Malaysian isolates. The
Australian isolates make less toxic mycolactone C whilst the Chinese isolates make
mycolactone D. Differences in structure are confined to the mycolactone side chain (Fig
1.2). The core lactone structure is conserved in all mycolactone congeners.
Recently a group of slow growing mycolactone procuding mycobacteria (MPM)
that make unique molecules have been identified (Table 1.1) (48, 49, 50). M.liflandii,
isolated from Xenopus tropicalus and Xenopus laevis frogs, makes mycolactone E (49).
M. pseudoshottsii and M. marinum DL, isolated from fish in the Chesapeake Bay and Red
and Mediterranean Sea respectively, make mycolactone F (48, 50). Both forms of
3

mycolactone are cytotoxic to L929 mouse fibroblasts, but are less potent than
mycolactones produced by M. ulcerans (48). To date, there have been no reported cases
of human infection by any of these MPMs. Mycolactone producing mycobacteria are all
though to have evolved directly from M. marinum (42)
The gross pathology associated with the disease has been attributed to
mycolactone (16). In addition to this, the slow growth rate directly translates to the slow
progression of the disease and the restricted low growth temperature makes the skin a
good target. The disease is characterized by severe subcutaneous necrotic lesions that
lead to chronic open sores and ulcerations, ultimately affecting bone in extreme cases
(Fig 1.3). It starts as a painless nodule localized mainly on the extremities and cooler
parts of affected individuals (21), with exceptional cases on the torso and buttocks (2). As
the disease slowly progresses, affected areas may progress to the ulcerative stage with
development of large ulcers with undermined edges (21, 22, 66). Oedema can be
extensive in some cases and in severe cases there may be bone involvement
(osteomyelitis) in some cases (62, 66). Bacteria can be identified in all forms of the
disease. Systemic infection is rarely encountered presumably because the bacteria can
notgrow at 37°C.
Unlike M. marinum that produces primarily intracellular infection in humans
triggering inflammatory responses, cell-mediated immunity (CMI) and delayed type
hypersensivity (DTH), M. ulcerans is mostly extracellular in acute disease (8). It is
thought that there might be a transient intracellular state during infection in which M.
ulcerans is taken up by macrophages and disseminated beyond the site of infection
followed by subsequent lysis of the immune cells to release extracellular bacteria (53,
63).
The difference in the pathology of M. ulcerans compared to other environmental
mycobacteria, especially its closest relative M. marinum, has been attributed to its
ongoing reductive evolution. M. marinum and M. ulcerans share 98% nucleotide
sequence identity, but over the course of evolution M. ulcerans has lost some of its
genome (51). There are over 700 pseudogenes in M. ulcerans which are intact in M.
marinum. Over 300 of these pseudogenes have been created by the insertion of two IS
4

elements, IS2404 and IS2606 which are highly represented in M. ulcerans but absent
from M. marinum. In the most virulent strains of M. ulcerans, the region of difference 1
(RDI) is absent (63). The RD1 locus encodes a secretory apparatus responsible for
exporting two antigenic immunomodulatory proteins ESAT-6 and CFP10 (60). In other
mycobacteria these proteins are crucial in enhancing virulence, and promoting expansion
and dissemination of the infection (8). Another major event in the evolution of M.
ulcerans was the acquisition of a large plasmid which produces mycolactone.
Mycolactone has also been shown to alter the immune system by suppressing the
production of interleukin-2 (IL-2) and tumor necrosis factor (TNF) thus down-regulating
T-helper-1 (Th1) responses (19, 40). This leads to a limited inflammatory response
during the acute and early stages of infection and explains why early detection of cases is
hampered (18). These events could contribute significantly to the induction and
regulation of immune responses in hosts (27).
Other factors may also contribute to the observed host response to infection such
as genetics of the affected individuals, previous mycobacterial infection and the extent of
an individual’s exposure to the bacteria in nature. For instance, it has been found that
individuals with prior BCG vaccination show reduced rates of ulcers upon infection (1,
61). However, there is not enough information to accurately outline which of these could
be determining risk factors for infectivity or variation in the virulence observed.

1.3 Diagnosis, Treatment and Control
Due to the painless nature of the disease and the lack of epidemiological data on
the incubation period, early stages of the diease are often ignored. Thus most affected
individuals report to health centers only after development of a large persistent ulcer. The
current diagnosis requires biopsies of affected tissue and analysis by Polymerase Chain
Reaction (PCR). Treatment in Buruli ulcer infections hence seeks to curtail the spread of
ulcers and repair existing tissue damage to affected areas. In early and intermediate stages
of the disease, anti-mycobacterial drugs including rifampicin and streptomycin or
amikacin are highly effective (53, 62). These drugs are used in combination and require
5

administration up to 8 weeks. In more advanced cases where larger lesions are involved,
complete surgical excision of the affected area remains the most effective treatment
option (5, 24). Surgery is typically followed by skin grafting and anti-mycrobacterials are
still administered to prevent relapses and accelerate the healing process. Traditional
treatments have also been used, and although some may be efficacious they leave behind
patients with severe scaring and disability. In some cases, in the natural history of the
disease, the immunosuppressive effect of the toxin is overcome by the host with
subsequent healing of ulcers (53). Deformities and scarring associated with healing are
common and this ultimately has a negative effect on the productivity of affected
individuals. There is a significant amount of stigma also associated with the disease (6,
55, 56).
Treatment in hospitals often requires long stays, up to 3 months, during which
serial surgeries and wound dressings are performed. The average cost of treating a Buruli
ulcer case was estimated to be US$ 780 per patient in 1994–1996 (68). For example, in
Ghana in 2001–2003, the median annual total costs of BU to a household by stage of
disease ranged from US$ 76.20 (16% of a work-year) per patient with a nodule to US$
428 (89% of a work-year) per patient who had undergone amputation (65).
There is no vaccine against Buruli ulcer disease. Current prospects include
generation of a live attenuated M.ulcerans, sub-unit based vaccines and improvement of
the BCG vaccine (26). There is evidence that the BCG vaccine may offer a cross-reactive
protective role, but this has not thoroughly been investigated (1, 26, 61))

1.4 Transmission
The mode of transmission of Buruli ulcer remains elusive. Person-to-person
transmission is rare and there has only been one reported case (11). For over 50 years, all
the regions of the world that have reported cases of Buruli ulcer have associated the
disease with proximity to rivers, swamps and watercourses in general. It is of importance
to note here that even though water bodies have been associated with the disease, the
clustering of cases does not necessarily correlate with the population distribution along
6

the watercourse. With the ongoing genome reduction of M. ulcerans, it is believed that
the bacterium is undergoing niche specialization, diverging from being a generalist
environmental bacterium to a more host specific bacterium. Despite intense investigation
with transmission , an amplifying reservoir has not been identified.
M. ulcerans DNA was first detected in the environment in the 1990s by PCR in
Africa by Franscoise Portaels in Naucorids and Belostomatids (45). M. ulcerans DNA
has subsequently been detected in a variety of aquatic organisms including
Belostomatids, Naucorids, Odonates, Coleopterans, mosquitoes, snails and small fish (15,
29, 34, 45, 51, 57). The DNA has also been detected in biofilm collected from the surface
of leaves and other inanimate objects and materials captured on 0.2µm pore filters (35.
67). Animals such koalas and possums have also been found to be naturally infected with
M. ulcerans (30, 43). Most of the DNA evidence has been based on the detection of the
insertion elements IS2404 and IS2606. Recently however, it has been shown that these
sequences are not unique to M. ulcerans and are present in other novel mycobacterial
species that also contain the mycolactone producing plasmid (26, 48) (Table 1.1 and Fig.
1.2).
Various attempts have been made to culture the organism from water, soil, insects and the
environment at large.These efforts are, however, thwarted by the overgrowth of faster
growing bacteria in the environment. There was one reported successful culture from a
Naucorid collected in the Ivory Coast (34). The culture however, could not be propagated
successfully in the lab and has since died out. More importantly, M. ulcerans has recently
been isolated from a Gerridae after serial passage of the insect homogenate through mice
(44). This isolate has been successfully been propagated and characterized.
Despite the significant efforts made toward identification of potential vectors and
reservoir species in the environment, the exact mechanism by which the bacterium is
introduced into unsuspecting hosts is still an enigma. There are three main hypotheses
involved in the transmission of the bacterium. M. ulcerans has been thought to be
introduced to persons through a preexisting wound; however this hypothesis has not been
tested. In 1997, Ross et. Al. published a report indicating that M. ulcerans can be
aerosolized from suspensions of tap water then be inhaled or ingested by otherwise
7

healthy individuals and subsequently reactivated in areas of the body where the
temperature is lower or where there has been some recent trauma (23).
Another hypothesis suggests that humans are primarily infected by traumatic
introduction of M. ulcerans into the skin through contact with a contaminated
environment (45). This could occur through injuries from sharp edges of leaves or twigs
or even insect vectors. The latter hypothesis has been supported with substantial research
by Marsollier et. Al. In a publication in 2002, Marsollier et. Al. carried out studies on
naïve Naucorids collected in France, where he infected these insects in the lab with M.
ulcerans and followed the infection over a period of 90 days. He was able to show that
the bacteria successfully colonized the insects, causing no growth impairment throughout
this period. He showed that the insects could transmit the bacteria to mice at the sites of
trauma when allowed to feed on their tails. In a later experiment, he showed that the
bacteria were localized in the salivary glands of infected insects. Although these studies
were of significance, it is difficult to determine their relevance to transmission of Buruli
ulcer in Africa for a number of reasons; (i) the insect species used were not African
species, (ii) the primary M. ulcerans used was not representative of the classical M.
ulcerans from Africa, and (iii) none of the studies have provided comprehensive
quantitative data on the location of the bacterium within the insect.
Considering the wide range of organisms that have been found positive for M.
ulcerans DNA within endemic aquatic water bodies, there is the possibility of a trophic
relationship between these organisms that could lead to a concentration of the bacteria
along the food chain and eventually introduction into a likely host. Naucorids and
Belostomatids are aggressive predaceous hemiptera, known to attack and immobilize a
wide range of prey even prey larger than themselves (59). Both insect families consume
small fish. Taking into account the fact that fish in endemic water bodies have been found
positive for potential M. ulcerans DNA based on detection of the IS2404 insertion
sequence, it is possible that there may be a transfer of the bacteria via this route.
Mycobacteriosis in fish has been well documented over the years (13, 32,
49,46,64). The three most important pathogenic species are M. abscessus, M. fortuitum
and M. marinum. More recently however, outbreaks of mycobacteriosis have been
8

reported within the Mediterranean and Red Sea and the Chesapeake Bay. These
infections have been attributed to newly recognized mycobacterial strains that are closely
related to M. ulcerans including M. marinum DL, M. pseudoshottsii, M. chesapeake and
M. shottsii (48, 49, 50) (Table 1.1). One striking revelation is that most of these novel
strains possess a plasmid that encodes for variants of the virulent macrolide toxin,
mycolactone, similar to the mycolactone produced by M. ulcerans (27, 42) (Fig 1.2).
Despite the historic association between mycobacteria and fish, no study has been done to
determine whether M. ulcerans can infect fish, thus being a possible link in the
transmission process.
In order to investigate potential reservoirs and vectors of Buruli ulcer, it is
important to obtain experimental data for their ability to colonize or cause disease in a
host. The key issues are to determine whether the bacterium colonizes and replicates
within these organisms. This can best be answered experimentally using laboratory
models. In this work, we have used an African insect species that has been found to have
positive PCR results for M. ulcerans in nature and a classical lineage strain of M.
ulcerans to determine the following: (i) whether M.ulcerans persistently colonizes or
grows within African predaceous water bugs, (ii) how the bacterium is partitioned within
external and internal body parts, (iii) whether mycolactone plays a role in insect
infections, and (iv) whether M. ulcerans can be transmitted by water bugs to prey within
a food chain. We have also developed an in vivo and in vitro model for understanding M.
ulcerans pathogenesis in fish by the following; (i) artificially infecting Japanese medaka
with M. ulcerans, (ii) determining the pathogenicity of M. ulcerans in medaka, (iii)
determining the role of mycolcatone in medaka infection (iv) determining whether M.
ulcerans can actively colonize and replicate in Medaka and (v) determining the
cytotoxicity of mycolatones to fish macrophages. This is the first study to address the
possibility that M. ulcerans survives and replicates in fish.
.
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Table 1.1.Mycolactone producing Mycobacterium isolates (Ranger et al., 2006)
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Figure 1.1: Geographic distribution of Buruli ulcer disease (Johnson et al., 2005).
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Figure 1.2: Mycolactone variations represented in naturally occurring isolates. The
core is the same in all these molecules with variations occurring in the side chains. (Pidot
et al., 2008)
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Figure 1.3. Buruli ulcer disease (WHO, 2004)
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Chapter 2: Materials and Methods
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2.1 Insect colonization studies
2.1.1. Bacterial strains and growth conditions
The strains used in this study and their sources are shown in Table 2.1. The
MU1615 strain is a well-characterized Malaysian human isolate with physical and
biochemical properties very similar to the genome strain Agy99 from Ghana and makes
mycolactone A/B. Transposon mutagenesis (12) was used to generate the mycolactone
negative mutant MU1615::Tn118 with an insertion in the FABH gene (mup045).
MU1615g and Mu1615::Tn118g express a green fluorescent protein via an integrating
vector psm5 (13). By using this method, the GFP gene is inserted into the chromosome of
MU1615 in the phage attachment site (att) and has no effect on the virulence of the
bacterium. All strains were grown to mid-log phase in Middlebrook 7H9 (M7H9) media
supplemented with 10% oleic acid-albumin-dextrose enrichment (OADC) {DIFCO}. M.
ulcerans and M. marinum 1218 strains were incubated at 32°C the MMDL strain was
incubated at room temperature and the XL5 strain was incubated at 28°C with 5% CO2.
2.1.2. Inoculum preparation
The total number of bacteria used for the infections was determined via colony
forming units (cfu). One loop-full of bacteria growing at exponential phase was
emulsified in 0.01% sodium dodecyl sulfate, and clumps were broken by being passaged
through a 25-gauge needle 15 times. One hundred microliters of the resulting suspension
was plated on M7H9 agar medium supplemented with 10% OADC (Difco) and incubated
at 32°C for 6 weeks to determine cfu.

2.1.3. Aquatic insects
Adult belostomatids (Appasus sp. [Diplonychus sp.]), 1- to 3-cm long were
collected from aquatic sampling sites in Ga district, Ghana. Insects were housed
individually in deep petri dishes filled with double-distilled water and maintained under a
12-h light and dark photoperiod at 28°C. Insects were fed either midge larvae
(Chironomidae) or blowfly larvae (Diptera: Calliphoridae) (Phormia regina) every other
day, and the housing water was changed at the same time. Mosquito (Ochlerotatus
24

triseriatus) egg rafts were obtained from Michigan State University. The egg rafts were
submerged in double-distilled water so that they could hatch into larvae in about 3 days.
Larvae were maintained on powdered fish food each day until they developed into third
instars, when they were fed bacteria and used for infection. Because some belostomatids
were collected from areas endemic for Buruli ulcer and M. ulcerans DNA has been
detected in a small number of belostomatids from West Africa, 110 belostomatids were
analyzed by using microscopy and PCR for the presence of M. ulcerans DNA. All insects
tested were PCR negative for M. ulcerans and therefore were used as negative controls.
2.1.4. Experimental infection of insects
Mosquito larvae infected with MU1615g via feeding were used as the primary
prey for adult belostomatids in these studies (Fig 2.1) . Infected prey were prepared by
starving the naïve larvae (Ochlerotatus triseriatus) for 24 h and then transferring them to
a fresh container containing 106/ml M. ulcerans bacteria in 10 ml of double-distilled
water, where larvae were allowed to feed on fluorescently tagged M. ulcerans for 24 h.
Five representative larvae were removed and analyzed for the presence of M. ulcerans by
using light (acid-fast stain) and fluorescent microscopy. At this time point, the guts of
virtually all larvae were packed with M. ulcerans. Three infected larvae were then fed to
each belostomatid that had previously been starved for 7 days. There were 36 adult
belostomatids per bacterial strain used. Twenty-four hours after infection, each insect was
transferred to a new petri dish and maintained on chironomid (Diptera: Chironomidae)
midge larvae for the duration of the study period. The water was changed each time
insects were fed.
2.1.5. Detection of M. ulcerans in insect tissues
For infection studies, 36 insects were used for each M. ulcerans strain tested. At 1
day, 30 days, and 60 days post infection (p.i.), 12 insects were sacrificed for analysis. The
24-h time point was chosen to determine the rate of infection, whereas the later time
points were chosen to detect viability, colonization, and multiplication of the bacteria
within the insects. At each time point, individual belostomatids’ internal organs were
carefully removed, and the salivary gland, gut, head, thorax, and forearms (Fig 2.2) were
homogenized in 200 µl of 1 M Tris-HCl buffer [pH 7.5]. For quantification of the
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bacteria, four 10-fold dilutions were made of each anatomical section, and smears were
made for acid-fast staining and fluorescent microscopy. Acid-fast bacilli (AFB) were
viewed with a light microscope (Olympus BX51/BX52). Wet mounts of each section
were viewed using a fluorescent microscope (Nikon Eclipse E400) equipped with a
standard epifluorescent attachment filter set for the detection of the fluorescently labeled
bacteria. Although AFB microscopy provided better visualization of M. ulcerans
morphology, the presence of fluorescently labeled M. ulcerans was required for scoring a
belostomatid positive for M. ulcerans as determined by microscopy. For scanning
electron microscopy, infected insects were vacuum dried, sputter coated with gold using a
SPI-Module sputter coater for 10 s, and mounted on carbon-coated metal stubs. Imaging
was performed on a Zeiss 1525 field emission scanning electron microscope equipped
with a GEMINI field emission column.
For recovery of viable bacteria from the infected insects, 100 µl of each insect
section homogenate was decontaminated via the modified Petroff’s method (15). Briefly,
150 µl of 4% NaOH was incubated with 100 µl of insect homogenate for 15 min,
followed by a 15-min incubation with 800 µl of sterile saline of the recovered pellet. The
resulting pellet, after centrifugation at 3,000 µg, was resuspended in 100 µl sterile saline
and plated on M7H9 agar plates supplemented with 10% OADC supplement (Difco),
chloramphenicol (20 mg/ml), and cycloheximide (20 mg/ml).
2.1.6. Transmission of M. ulcerans infection to blowfly larvae via feeding
Twelve infected belostomatids removed at 1 day, 30 days, and 60 days p.i. were
allowed to feed individually on a single blowfly larva (Phormia regina). Larval exuviae
were collected immediately, homogenized as described above, and analyzed by using
microscopy and PCR for the presence of M. ulcerans. As controls, uninfected
belostomatids were also allowed to feed on larvae and were analyzed for the presence of
M. ulcerans.
2.1.7. DNA extraction and PCR analysis
DNA was extracted from insect and larval homogenates with the UltraClean soil
DNA extraction kit (Mo Bio Laboratories) according to the manufacturer’s instruction.
The enoyl reductase (mlsA) gene was chosen to determine the presence of mycobacterial
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DNA in insect tissues as previously described (14). Five microliters of each DNA sample
was amplified with the mlsA primer pair 5’-GAGATCGGTCCCGACGTCTAC-3’ and
5’-GGCTTGACTCATGTCACGTAAG-3’ in 50-µl PCR mixtures using the GoTaq
polymerase buffer system (Promega). Each reaction mixture contained 36.7 µl doubledistilled water, 5 µl GoTaq green master mix (400 µl of each deoxynucleoside
triphosphate, 3 mM MgCl , blue and yellow dyes), 1 µM of forward and reverse primers,
2

1.5 U of GoTaq polymerase, and 5 µl of DNA template. Cycling was performed in a
Mastercycler gradient thermal cycler (Eppendorf) as follows: 95°C for 5 min; 35 cycles
of 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min; and 72°C for 10 min. Nine
microliters of each reaction mixture was analyzed on 1.5% agarose gels in 1µM Trisacetate-EDTA stained with 1 µg/ml ethidium bromide for visualization of amplicons.
2.1.8. Statistical analysis
Statistics were calculated using STATA version 10.0. For the analysis of numbers
of anatomical sections positive for microscopy and PCR, the Mann Whitney rank sum
test was used. For the analysis of differences between MU1615g and MU1615::Tn118g
infected belostomatids, P values were calculated for the number of insects positive for
bacteria as determined by either microscopy or PCR using the Mann-Whitney test for
comparison of two groups. Z values correspond with the strains used. A positive value
indicates greater significance with MU1615g than MU1615::Tn118g. A negative value
means greater significance with MU1615::Tn118g than MU1615g.
2.2. Insect microflora studies
2.2.1. Aquatic insects
Adult belostomatids (Appasus sp. [Diplonychus sp.]), 1 - 3cm long were collected
from aquatic sampling sites in Ga district, Ghana. Adult naucorids (Naucoris sp.), 0.5 - 1
cm long were also collected from aquatic sampling site in Ga district, Ghana. Insects
were housed individually in deep petri dishes filled with double-distilled water and
maintained under a 12-h light and dark photoperiod at 28°C. Insects were fed either
midge larvae (Chironomidae) or blowfly larvae (Diptera: Calliphoridae) (Phormia
regina) every other day, and the housing water was changed at the same time.
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2.2.2. Culture-dependent methods of isolating bacteria
Ten uninfected belostomatids and naucorids were used for this study. The external
parts of the insect were surface sterilized with 70% ethanol prior to dissection of salivary
glands, head, thorax and gut. The sections were homogenized in 500 µl of sterile saline
with a mortar. One hundred microliters of the resulting homogenate was aliquoted out
and serially diluted 10-fold up to 10-5. Fifty microlitres of the resulting solutions was
plated directly onto Middlebrook 7H9 (M7H9) media supplemented with 10% oleic acidalbumin-dextrose enrichment (OADC) {DIFCO} and LB agar plates (DIFCO). The
plates were incubated at 37°C for 24 – 48 h. The M7H9 mycobacterial media was used to
isolate bacteria that were likely to compete with M.ulcerans recovery from infected
insects. The nutrient rich LB media was used to isolate dominating and supporting
microflora from the insects.
Plates were screened for bacterial growth. Forty colonies from each media type
were selected for sub-culture and further screening. After three sub-culture passages, 47
colonies were randomly selected based on colony morphology, color, elevation, size,
margin and frequency of occurrence. The morphology of the bacterial isolates was also
determined by gram staining. The selected bacterial isolates were further characterized
based on their distinctive metabolic properties. The isolates were plated individually onto
selective media including gelatin, urea slants, triple sugar iron slants, MacConkey agar
and Simmons citrate agar to identify their ability to produce gelatinase and urease,
ferment sugars and lactose and utilize citrate as the sole carbon source respectively.
2.2.3. Antibiotic susceptibility testing
A Kirby Bauer test (2) was also conducted to identify susceptibility of bacteria to
various antibiotics. Each bacterial isolate was cultured in LB broth medium for 24 hours.
One hundred microliters of the resulting broth cultures was spread plated onto a Mueller
Hinton agar plate and tested against 12 different antibiotic discs: Ampicillin 25 µg,
Carbenicillin 100 µg, Streptomycin 10 µg, Tetracyclin 10 µg Chloramphenicol 10 µg,
Gentamycin 10 µg, Ciprofloxacin 30 µg, Clindamycin 30 µg, Penicillin 10 units,
Amikacin 100µg and Sulphonamides10 µg were equidistantly dispensed on the M-H
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plates. The plates were incubated for 24 h at 37°C and the zones of inhibition of bacterial
growth were measured and recorded as described.
2.2.4. Culture independent methods of bacterial identification
Bacterial DNA was isolated as described above from the insect homogenates. The
16S ribosomal RNA gene was amplified using universal bacterial primers (9). The PCR
reactions were performed according to the following; 5µl of each DNA sample was
amplified with the forward primer UnivBacF 5’-AGGAGGTGATCCAACCGCA-3’ and
reverse primer UnivBacR 5’-GAGGAAGGTGGGGAT-3’ in 50-µl PCR mixtures using
the GoTaq polymerase buffer system (Promega). Each reaction mixture contained 36.7 µl
double-distilled water, 5 µl GoTaq green master mix (400 µl of each deoxynucleoside
triphosphate, 3 mM MgCl , blue and yellow dyes), 1 µM of forward and reverse primers,
2

1.5 U of GoTaq polymerase, and 5 µl of DNA template. Cycling was performed in a
Mastercycler gradient thermal cycler (Eppendorf) as follows: 95°C for 5 min; 35 cycles
of 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min; and 72°C for 10 min. Nine
microliters of each reaction mixture was analyzed on 1.5% agarose gels in 1µM Trisacetate-EDTA stained with 1 µg/ml ethidium bromide for visualization of amplicons.
2.2.5. Cloning and sequencing
The amplified partial 16S rRNA gene PCR products were cloned into vectors by
ligating them into PCR 2.1 TOPO vector system (Invitrogen) according to the
manufacturer’s instructions. The ligated products were transformed into competent E.
coli DH5α vectors and resulting transformants were grown on LB plates supplemented
with100 μg mL-1 each of ampicillin, X-gal and Isopropyl β-D-1-thiogalactopyranoside.
Isolated white colonies that grew upon 24 h of incubation were selected for plasmid DNA
extraction (Qiagen mini prep) and subsequent sequencing. Sequencing reactions were
performed using the Big Dye terminator v3.1 kit (Applied biosystems). Purified DNA
was sequenced using the M13 forward (5’-GTAAAACGACGGCCAG-3’) and reverse
primers (5’-CAGGAAACAGCTATGAC-3’) which flank the inserted partial 16SrRNA
DNA sequence. Sequence analysis was performed by using the BLASTn search software
(GenBank).
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2.3 Fish In vitro Studies
2.3.1. Tissue culture
The adherent carp monocyte cell line CLC (European Collection of Cell Cultures
no. 95070628) was a kind gift from Jeffery Cirillo (Texas A&M Health Science Center).
Cells were maintained at 28°C and 5% CO2 using high glucose MEM (Gibco)
supplemented with 10% essential amino acids (Gibco), 10% heat-inactivated fetal bovine
serum (Gibco) and 2mM L-Glutamine as previously described in (4). Cytopathicity
assays were performed in 24-well tissue culture plates.
2.3.2. Mycolactone sensitivity assay
Mycolactones from MU1615, MMDL, and XL5 were extracted as described
previously in (6, 10). Briefly, lipids were extracted with chloroform –methanol (2:1,
vol/vol), and phospholipids were removed by precipitation with ice-cold acetone to
obtain acetone-soluble lipids (ASLs). Acetone soluble lipids were serially diluted in
tissue culture medium and added to cells in a 24-well tissue culture plate. Cytopathicity
was defined as the minimal concentration of mycolactone necessary to produce cell
rounding in 24 h and loss of the monolayer by 48 h (1).
2.3.3. LDH release and apoptosis
Fish monocytes (CLC cells) were assayed for cell death via apoptosis and
necrosis. Apoptosis and necrosis were measured using a colorimetric kit from Promega as
previously described (1). Briefly, cells were suspended in culture media and seeded in a
96 – well tissue culture plate. The release of cytoplasmic lactate dehydrogenase from
mycolactone treated and permeabilized cells was measured at 24 h p.i. using the
colorimetric kit following the manufacturer’s instructions. Background release of LDH
was determined from lyses of ethanol treated cells according to the manufacturer’s
protocol. The percentage of LDH release was then computed using the following
calculation: [(release of LDH from mycolactone treated cells – background release from
ethanol-treated cells)/ (maximum release of LDH by cell lysis – background release)] ×
100.
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Apoptosis of mycolactone treated CLC cells was measured at 24 h p.i. by using the Cell
Death Detection Plus enzyme-linked immunosorbent assy (Roche, Indianapolis, IN) as
described previously in (1). Apoptosis was determined as fold enrichment of
nucleosomes [(measurement of DNA-histone complex from treated cells/background
measurement of untreated cells)].

2.4 Fish In vivo Studies
2.4.1. Medaka aquaculture
Japanese Medeka used in this study were obtained from Don Ennis (University of
Louisiana, Lafayette, LA, USA). Medaka were maintained in the laboratory in aquaria at
28°C, as described in (3). Fish were infected with mycobacteria and maintained post
infection in a BSL-2 laboratory at 28°C.
2.4.2. Experimental design
Two infection experiments were performed in this study as outlined in Figure
2.4A and B. Bacterial inocula was prepared as described above and diluted in PBS to
obtain a concentration range of 102-108. Medaka were anaesthetized with tricaine
methanesulphonate (MS-222) (0.0175%) and injected with 30µl of bacterial suspension
at respective doses. Sham infections were also performed where medaka were inoculated
with 30µl of sterile PBS. All fish were maintained separately under similar environmental
conditions and monitored for survival, mortality, gross behavioral changes and gross
morphological pathology.
2.4.3. Histopathology
At the set time points (Figure 2.4A and B), 1-3 infected fish were euthanized
using an overdose of tricaine methanesulphonate (MS-222) (0.1%). Fishes were
processed whole in 10% neutral-buffered formalin followed by embedding in paraffin
wax. Thin sections of the paraffin embedded fish were made and stained with
hematoxylin and eosin (H&E) and Ziehl-Neelsen acid fast stain. The morphological
pathology and presence of acid fast bacilli (AFB) present in the fish tissues was scored
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between bacterial strains used and within doses of inoculum delivered respectively.
―Sham‖ control infected fish were sacrificed and subjected to similar treatments for
comparison.
2.4.4. Microscopic evidence of microbial colonization
Between 4 to 9 bacteria-infected Medaka were euthanized as described above at
the time points shown in figure 2.4A and B. Each fish was dissected by making a single
anterior to posterior incision along the abdomen followed by removal of the kidney, liver,
spleen, gut and heart. Whole organs of fish infected with fluorescently labeled bacteria
were inspected microscopically as described in (3). Briefly, fish organs were placed in a
petri dish and observed for fluorescence using a Nikon SMZ800 (Nikon, Tokyo, Japan)
stereomicroscope equipped with X-cite TM 120 for fluorescence. The organs as well as
the remaining fish carcass were kept separate and homogenized in 500µl of M7H9 broth
media supplemented with 100µg/ul cyloheximide, 20µg/ul chloramphenicol and 25µg/ul
ampicillin. For detection of AFB in the dissected organs, smears were made from the
homogenized suspensions and stained using the Zeihl-Neelsen technique. AFBs were
viewed light microscopy using an Olympus BX51 microscope (USA). Wet mounts of
representative organs were viewed using a Nikon ECLIPSE E400 fluorescent microscope
for the detection of the fluorescently labeled bacteria.
2.4.5. PCR analysis of infected Tissue
DNA was extracted from organ homogenates using a protocol adapted from
Lamour and Finely (8). Amplification of the enoyl reductase (mlsA module of the
mycolactone plasmid) gene was chosen to determine the presence of MU1615g and
MU1615::Tn118g DNA in fish tissues. The early secreted antigen protein (ESAT-6) gene
was chosen to determine presence of MMDL240490 and MM1218 in fish tissues. Two
and a half microlitres of each respective DNA sample was amplified with the mlsA
primer

pair;

5’–

GAGATCGGTCCCGACGTCTAC-3’

GGCTTGACTCATGTCACGTAAG-3’

or

and

5’-

the ESAT-6 primer pair; 5’ –

GACAGCAGCAGTGGAATTTCG – 3 and 5’ – CTTCTGCTGCACACCCTGGTA – 3
in 25µl polymerase chain reaction mixtures using the GoTaq polymerase-buffer system
(Promega). Each reaction contained 18.3µl double-distilled water, 2.5µl GoTaq green
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master mix (400µl of each deoxynucleoside triphosphate, 3mM MgCl2, blue and yellow
dyes), 0.5µM of forward and reverse primers, 0.75U GoTaq polymerase each and 5µl of
DNA template. Cycling was performed in a Matercycler gradient thermal cycler
(Eppendorf) as follows: 95°C for 5 min; 35 cycles of for 95°C for 1 min, 55°C for 1 min
72°C for1 min; and 72°C for 10 min. Seven microlitres of each reaction mixture was
analyzed on 1.5% agarose gels in 1X Tris-acetate-EDTA stained with 1µg/ml ethidium
bromide for visualization of amplicons.
For quantitative PCR, DNA was extracted as described before. Genome forming
units of MU1615g and MU1615::Tn118g in fish tissue were quantified by the
exponential detection of expression levels of an internal probe designed for the enoyl
reductase gene. Five microlitres of representative DNA was amplifed with the mlsA
primer pair; 5’- CGCCTACATCGCTTTGG -3’ and 5’- ATTGAATCGCAGCCATACC
-3’ and an internal probe; 5’ -TET CTGATCCATGCCGGCA MGBNFQ -3’ in 25µl
polymerase chain reaction mixtures using the fluorescent Taqman PCR system. Each
reaction mixture contained 3µl double-distilled water, 12.5µl environmental mastermix,
1µl each of forward and revers primers and 2.5µl probe. Cycling and detection of the
Taqman fluorophore was performed in an Applied Biosystems Division 7700
thermocycler and sequence detector.
2.4.6. Statistical analysis
Statistics were calculated using SPSS version 17 and GraphPad Prism version 4
software. For the analysis of cytotoxicity via apoptosis and LDH release, the Students ttest was used to determine significant differences between the congeners of mycolactone
used. For the analysis of percent survival of Medaka post infection with different
mycobacteria, standard deviations were computed to determine significance. For analysis
of numbers of infected organs that were AFB and ER-PCR positive within and between
strains, the Mann-Whitney test for comparison of two groups was used to determine
significance.
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Table 2.1. Mycobacterial strains used for this study
Strain

Species

Host

Geographic

Charateristics

origin

Reference or
source

MU1615

M. ulcerans

Human

Malaysia

Wild-type strain. Makes Mycolactone A/B

ATCCa

MU1615g

M. ulcerans

Human

Malaysia

Wild-type strain. Makes Mycolactone

ATCCa

A/B. Intrinsically expresses green
fluorescent protein (gfp)
MU1615::Tn118

M. ulcerans

Human

Malaysia

Mycolactone negative mutant due to

ATCCa

insertion in FabH gene via transposon
mutagenesis
MU1615::Tn118g

M.ulcerans

Human

Malaysia

Mycolactone negative mutant due to

ATCCa

insertion in FabH gene via transposon
mutagenesis. Intrinsically expresses green
fluorescent protein (gfp)
MU01G897
1218

M. ulcerans
M. marinum

Wild – type. Makes mycolactone A/B
Wild-type strain.

4
ATCCb

Red Sea Israel

Wild-type strain. Makes mycolactone F

11

Frog (Xenopus

University of

Wild – type strain. Makes mycolactone E.

10

laevis)

Virginia

Human
Salt water fish

French Guyana
United States
marine captive

MMDL

M. Marinum

Sea Bass

DL240490

(Dicentrarchus
labrax)

XL5
a

M. liflandii

ATCC – American Type Cell Culture 35840

b

a

ATCCb – American Type Cell Culture 927
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Figure 2.1: Location of acid-fast (bright-field microscopy) and GFP-labeled
(epiflourescence microscopy) MU 1615g in mosquito (Ochlerotatus triseriatus) larva
gut.
Total magnification = 1000X

38

Figure 2.2: Images of dissected belostomatid, showing the relative sizes of the
following insect compartments assayed in this study: head (A), raptorial arms (B),
thorax (C), salivary glands (D), and gut (E).
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Figure 2.4A: Experimental design 1 for fish in vivo study
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Figure 2.4B: Experimental design 2 for fish in vivo study
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Chapter 3: Persistent Association of Mycobacterium ulcerans
with West African Predaceous Insects of the Family
Belostomatidae
This chapter is a lightly revised version of a paper by the same name published in the
journal Applied and Environmental Microbiology in 2008 by Lydia Mosi, Heather
Williamson, John R. Wallace, Richard Merrit and Pamela L. C. Small:

Lydia Mosi, Heather Williamson, John R. Wallace, Richard W. Merritt, and P. L. C.
Small. Persistent Association of Mycobacterium ulcerans with West African Predaceous
Insects of the Family Belostomatidae. Applied and Environmental Microbiology Vol. 74,
No. 22. 7036-7042
My use of ―we‖in this chapter refers to my co-authors and myself. My primary
contributions to this paper include (1) selection of the topic and development of the
experiments, (2) Most of the gathering and interpretation of literature, (3) statistical
analysis of the data, (4) pulling the various contributions into a single paper, and (5) most
of the writing.
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3.1 Introduction
Mycobacterium ulcerans disease (Buruli ulcer) continues to be one of the most
debilitating cutaneous diseases in West Africa. Although the distribution of the disease is
global and affects people of all ages, the burden of disease is most severe in West Africa,
where Buruli ulcer is an emerging disease. In West Africa, cases typically occur among
rural, economically deprived populations (11, 31). M. ulcerans is an environmental
pathogen; however, the method of transmission from the environment to humans remains
elusive (5, 11, 32). Person-to person transmission of Buruli ulcer is extremely rare, and a
large body of evidence implicates exposure to slow moving or stagnant water as the most
universally defined risk factor for infection (23, 25). A striking characteristic of the
disease in all regions is its discontinuous focal distribution. Villages where the disease is
endemic and those where it is not endemic may be found within a few kilometers of each
other along a waterway (23, 25, 26).The absence of the disease in arid parts of the world
strongly suggests that environmental constraints may limit the distribution of disease. In
addition, there is a strong association of the bacterium within aquatic ecosystems.
The possibility of the bacterium being concentrated through trophic links and
ultimately delivered to an unsuspecting host, via a vector or some other unknown route,
has been suggested by several investigators (6, 14). A major advance in understanding
transmission occurred with the detection of M. ulcerans DNA in predaceous insects
(Naucoridae and Belostomatidae), leading to the hypothesis that insects may be involved
in the transmission (20). Naucorids and belostomatids are aquatic hemiptera that exploit a
wide range of prey, including snails, fish, anuran larvae, and other terrestrial and aquatic
insects (29). Both insect groups are found worldwide near vegetative areas of stagnant
water bodies. Although they do not feed on humans, they can bite if they are disturbed
and for this reason are called ―toe biters.‖ Subsequent work from Ghana and Cote
d’Ivoire has confirmed the presence of M. ulcerans DNA in a large number of aquatic
invertebrate and vertebrate taxa (6, 18, 20, 21). None of the predaceous hempitera that
were found to have positive PCR results for M. ulcerans DNA in Africa are
hematophagous, and the percentage of biting hemiptera is often quite low in areas where
the disease is endemic (2).There have been numerous unsuccessful attempts to culture the
bacterium from the environment due to competition from other, faster-growing
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environmental bacteria. A major breakthrough occurred with the successful culture of M.
ulcerans from a water strider (Gerridae) collected in Benin by Francoise Portaels et al.
(22).
In addition to extensive field work on the occurrence of M. ulcerans in natural
environments, the potential role of biting hemiptera as vectors of M. ulcerans has been
extensively explored in a set of elegant laboratory studies conducted by Laurent
Marsollier et al. (13, 15, 16). In these studies, dipteral larvae (Phormia terrae-novae) were
injected with suspensions of M. ulcerans and subsequently fed to Naucoris cimicoides,
collected from swamps in France (13). Marsollier and colleagues showed from these
studies that M. ulcerans successfully colonized the insect over a period exceeding 90
days, causing no growth impairment or death of the insect. More interestingly, they
showed through microscopy that whereas wild-type bacteria could be detected on the
raptorial arms of naucorids, the majority of organisms were localized in the salivary
glands of the insect. Finally, Marsollier et al. (15) also presented data supporting the role
of the M. ulcerans cytotoxic macrolide toxin, mycolactone, in colonization of the insect.
Although these studies were of significance, it is difficult to determine their
relevance to transmission of Buruli ulcer in Africa for a number of reasons. First, the
species of Naucoridae used was from France, not Africa where Buruli ulcer is endemic.
Second, the bacterial strain used for most of these studies is a member of the ―ancestral‖
lineage of M. ulcerans rather than a member of the ―classical‖ lineage associated with
severe Buruli ulcer in Africa and Malaysia (12). To investigate the ability of M. ulcerans
to colonize aquatic African hemiptera, we infected adult belostomatids collected in
Ghana with a ―classical‖ isolate of M. ulcerans. We also employed a mycolactonenegative mutant of M. ulcerans to determine the role of mycolactone in insect
colonization. We showed that belostomatids can be persistently colonized by both
mycolactone-producing and mycolactone-negative M. ulcerans; however, we obtained no
evidence of replication within internal insect organs. We showed extensive colonization
of the exoskeleton and showed that M. ulcerans is transmitted to prey via feeding. In our
infection model, we demonstrated the significance of trophic-level transfer of M.
ulcerans in the environment in which naturally infected mosquito larvae successfully
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passed M. ulcerans up the food chain. These results provide a useful model for beginning
to understand the ecology ofM. ulcerans in West Africa.

3.2 Results
3.2.1. Mycobacterium ulcerans exhibits prolonged infection in African Belostomatids.
We showed that throughout the 60-day study period, all of the belostomatids that
had been infected with M. ulcerans 1615 GFP were shown to be positive for the bacteria
as determined by either microscopy, PCR analysis, or both (Table 3.1). Based on
microscopy and PCR, there was a 100% infection rate as determined by the presence of
M. ulcerans in 12/12 insect guts after 24 h (Table 3.2 ). This amount declined
significantly (P = 0) to 9% at 30 days p.i., with only one gut being AFB positive, and rose
slightly to 30% at 60 days. This increase was not statistically significant (P = 0.8357).
There was a low infection rate of the salivary glands assayed at all time points, with a
mean of 12% insects shown to be positive for bacteria as determined by microscopy for
M. ulcerans. By using PCR analysis, however, the average rate of infectivity over time
was much higher (63%). The rates of infection in the head, raptorial arms, and thorax
followed similar patterns. The largest number of M. ulcerans-positive insects for these
three anatomical sections averaged 88% and occurred at 30 days p.i. This increase
between 1 day p.i. and 30 days p.i. was statistically significant, with P values of 0.05,
0.0003, and 0.0004, respectively. Between 30 days and 60 days, even though there was a
decrease in the number of insects that were positive for bacteria on the head, raptorial
arms, and thorax, the difference was not significant.
There was some discrepancy between PCR and microscopy results for the
percentage of insects positive for M. ulcerans (Tables 3.2, 3.3). There were significantly
more insects shown to be positive as determined by PCR analysis in the head, raptorial
arms, and salivary glands at 1 day p.i. (P = 0.02, 0.001, and 0, respectively). By using
microscopy, at 30 days p.i. there were significantly more insects shown to be positive for
bacteria on the head, raptorial arms, and thorax (P = 0.0006, 0.02, and 0.0006,
respectively). Contrary to the decrease in the number of insects that were positive for M.
ulcerans at 60 days p.i. in the gut, there was a significant increase determined by PCR
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analysis (P = 0.002). All insect sections that were shown to be positive for bacteria by
bright field microscopy were also positive for GFP bacilli, thus strengthening the
observation. A total of three insects died prior to the day 30 and day 60 time points;
however, the deaths were not attributed to any effect of M. ulcerans but rather to natural
causes. A similar death rate occurred among the uninfected insects.
3.2.2. M. ulcerans increases in external compartments and decreases in internal organs
over 60 days.
In order to quantitatively determine multiplication of M. ulcerans within the
infected insects, dissected anatomical sections were homogenized, decontaminated by the
modified Petroff’s method, and cultured on M7H9 medium supplemented with OADC
and 20µg/ml each of chloramphenicol and cycloheximide. These efforts, however, were
mostly frustrated by the overgrowth of faster-growing bacteria and fungi present in many
insects. The salivary glands produced little bacterial growth and no isolates of M.
ulcerans. For this reason, a semi quantitative method for obtaining evidence for the
growth of M. ulcerans was employed based on detection and enumeration of acid-fast
and GFP positive bacilli present in dilutions of insect section homogenates. Results from
these studies showed that the bacterial load on the exoskeleton (head, raptorial arms, and
thorax) was greater than that in the internal organs (salivary glands and gut) at all time
points (Fig. 3.1, 3.2, 3.3). Since the primary infection of the belostomatids was performed
orally, it was expected that the insect guts would have a large amount of bacteria
compared to other anatomical sites at early time points, and this phenomenon was indeed
observed. However, bacterial density dropped significantly (P = 0.0003) in the gut by the
60-day time point. The mean bacterial density within the salivary gland remained below
10 detectable bacterial cells for all time points without any significant changes. In
contrast, anatomical sections of the insect covered by a substantial exoskeleton showed a
significant and steady increase in density of detectable bacteria over the 60-day study
period with as many as 1,000 bacterial cells seen per viewing field at 1000×
magnification (P values of 0.05, 0.01, and 0.019 for head, raptorial arms, and thorax,
respectively).
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3.2.3. M. ulcerans is efficiently transmitted from infected belostomatids to blowfly larva
through feeding
Belostomatids feed by grabbing and immobilizing prey with their raptorial arms
and sucking out prey contents with their stylet (28). In order to determine the ability of
M. ulcerans-infected belostomatids to transmit M. ulcerans through grabbing and biting,
blowfly larva exuviae, which were fed to infected belostomatids, were analyzed for the
presence of M. ulcerans by using microscopy, PCR analysis, and culture (Fig. 3.4). Each
insect prior to being sacrificed at 1 day, 30 days, and 60 days p.i. was given a naïve
blowfly larva. Larva exuviae collected at each time point were pooled for analysis. M.
ulcerans could be detected by using microscopy (Fig. 3.5) and PCR analysis (data not
shown) in all exuviae. Even 60 days after infection with M. ulcerans, belostomatids were
still able to transmit M. ulcerans to naïve blowfly larvae through feeding. The attempt to
culture back from the blowfly larva exuviae was unsuccessful even after decontamination
of samples due to overgrowth of native bacteria. In this experiment, 100% infectivity of
maggot exuviae was found as determined by both PCR and microscopy, indicating a
direct transmission of bacteria from the insects to their prey.
3.2.4. Mycolactone is not required for the colonization of belostomatids.
Insects that were infected with the mycolactone-negative strain MU1615::TN118g
showed patterns of persistence within African belostomatids similar to those of
MU1615g bacteria (Tables 3.1, 4 and 5). As stated earlier, each infected insect was
dissected into five anatomical sections, homogenized, and assayed for the presence of the
bacteria. There was a 100% infectivity of insect guts 1 day p.i. as determined by both
microscopy and PCR. This efficiency decreased steadily over time to 25% insects at 60
days p.i. as determined by microscopy. However, PCR analysis showed there was a
significant increase in the number of insect guts that were positive for bacteria (P =0.04).
Similarly, the salivary glands of the insects were the least infected, and there were no
significant differences in the number of positive results as determined by either
microscopy or PCR. There were comparable numbers of insects that were positive for
bacteria on the head, raptorial arms, and thorax as determined by either microscopy or
PCR, and there was no significant difference between the two methods, with the
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exception of more positive results for bacteria on the head at 30 days and 60 days p.i.,
shown by microscopy. More importantly, there were very few significant differences
between the number of insects positive for MU1615g and MU1615::TN118g
(mycolactone negative), as determined by either microscopy or PCR (Table 6). Similarly,
the external surfaces of the insects showed the highest bacterial density over time. At 1
day p.i.,there were significantly more insect raptorial arms positive for the mycolactonenegative strain than for the wild type (P = 0.0004). At 30 days p.i., there were
significantly more insects with wild-type-infected raptorial arms and thoraces than there
were mycolactone negative-infected insects (P = 0.003 and 0.0001, respectively). There
were no significant differences between MU1615g and mycolactone-negative
MU615::TN118g infected insects 60 days p.i. In the salivary glands and guts, the
bacterial density decreased significantly over the 60-day period, and there was no
significant difference between this observation and that of MU1615g infected insects.

3.3 Discussion
The hypothesis that M. ulcerans is a vectored pathogen which is transmitted to
humans via the bite of predaceous water bugs has received considerable attention (2, 13,
17, 24).The interpretation of the data presented in earlier studies has been complicated by
the following three major issues: (i) the insect species used were not African species, (ii)
the primary M. ulcerans used was not representative of the classical M. ulcerans from
Africa, and (iii) none of the studies have provided provided comprehensive quantitative
data on the location of the bacterium within the insect. In this study, we have used an
African insect species that has been found to have positive PCR results for M. ulcerans in
nature and a classical lineage strain of M. ulcerans to determine the following: (i)
whether M. ulcerans persistently colonizes or grows within African predaceous water
bugs, (ii) how the bacterium is partitioned within external and internal body parts, (iii)
whether mycolactone plays a role in insect infections, and (iv) whether M. ulcerans can
be transmitted by water bugs to prey within a food chain. Although, like Marsollier and
colleagues, we show extensive colonization of the exoskeleton of belostomatids by M.
ulcerans (Fig. 3.2, we do not have convincing evidence of bacterial growth and
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replication in the internal compartments of belostomatids. We found very low numbers of
M. ulcerans in the salivary glands of belostomatids at all times, in contrast to the work of
Marsollier et al. We initially thought that the differential findings of our laboratory and
those of Marsollier and colleagues might be due to the use of different lineages of M.
ulcerans. However, when tested under comparative conditions, we found no major
differences between the ancestral and classical strains in their abilities to associate with
belostomatids (data not shown).
We also ruled out the possibility that the colonization of external compartments of
belostomatids occurred as an artifact of the infection method. In previous studies, and in
early work in our lab, M. ulcerans bacteria were injected into blowfly larvae. During this
procedure, inoculum leaks out of the larva, producing a significant amount of surface
contamination which could be transferred to the insect’s raptorial arms when it grasps
prey for feeding. We were able to avoid this problem by taking advantage of the fact that
mosquito larvae readily ingest bacteria and in turn are consumed by predaceous water
insects higher up the food chain. Nonetheless, in our work, as in the work of Marsollier
and colleagues, considerable colonization of raptorial arms occurred (Fig. 3.2).
Belostomatids use their arms for grooming their stylet as well as for grabbing prey
(28). This behavior could also lead to colonization of the raptorial arms. In accordance
with Marsollier and colleagues, we showed that infected insects could transmit M.
ulcerans via feeding; however, this transfer of bacteria is most likely to have occurred
through contact with the heavily colonized raptorial arms and other external parts rather
than the salivary glands.
We do not find that the mycolactone toxin plays a significant role in the ability of
M. ulcerans to persist within insects because both toxin-positive and isogenic toxinnegative strains persist equally. The evidence for the impaired ability of mycolactonenegative strains to colonize French naucorids rested on a 10-fold difference between
wild-type and mycolactone-negative strains, which was minimal considering the length
of the experiment (15). Despite the fact that we collected insects three times during field
trips to Ghana, we never obtained sufficient numbers of naucorids to produce statistically
sound data. We did, however, conduct limited studies with the small number of naucorids
we were able to collect. Results from these studies were similar to those using
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belostomatids in that we did not see any evidence of replication in the salivary gland, but
the numbers of insects and time points were too few for statistical analysis.
The presence of the numerous and complex microbial flora found in
belostomatids, especially in the gut, made it impossible to obtain any M. ulcerans cfu.
Despite the fact that we detected few other bacteria in the salivary glands, we did not
obtain a culture of M. ulcerans. The long-term instability of GFP under neutral pH
suggests that the presence of fluorescent M. ulcerans in belostomatids is consistent with
the presence of viable organisms. We did show long-term colonization of belostomatids
by M. ulcerans using direct smear microscopy and PCR.
With respect to methodology, we did not always find a concordance between
microscopy and PCR results. Similar results have been reported in other studies (1, 3, 8,
9, 10, 19). The direct smear method of detecting acid-fast bacilli has a sensitivity range of
between 40 to 85% and a specificity of 67 to 100% (4, 8). The degree of sensitivity of
PCR for the detection of pathogens within specimens has rendered it the method of
choice for most studies (19). Where false positivity has been suspected with PCR,
microscopy has been used to confirm the accuracy of positive PCR results in some cases
(1, 9, 10). Generally, the power of detection of the bacterium of interest is increased by
the use of both methods. Our findings support the hypothesis that predaceous aquatic
insects may play an important role in maintaining M. ulcerans within food webs in the
aquatic environment (2). In this respect, external contamination of insect skeletons could
also play a role because we have observed tadpoles grazing on the surfaces of predaceous
water bugs in microcosm environments (H. Williamson, unpublished data). We also
cannot rule out the possibility that belostomatids may be involved in mechanical
transmission of M. ulcerans.
Finally, this work suggests that M. ulcerans can live as a commensal on
belostomatids (2, 33). It is surprising that neither mosquito larvae nor belostomatids
suffer developmental or behavioral defects as a result of M. ulcerans infection. Likewise,
M. ulcerans appears to survive on the exoskeleton of belostomatids and within the guts of
mosquito larvae for long periods of time. This close association between bacterium and
insect, which is neither detrimental nor beneficial, is the hallmark of commensalism in
nature.
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3.5. Appendix
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Table 3.1: Distribution of Acid-fast and PCR positive insects post infection with
MU1615g
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Table 3.2: Number of infected belostomatids positive for MU1615g by microscopy
and PCR (by anatomical site)
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Table 3.3: Distribution of Acid-fast and PCR positive insects post infection with
MU1615::Tn118g
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Table 3.4. Persistence of MU1615g in specific anatomic compartments as
determined by microscopy and PCR
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Figure 3.1: Average number of MU1615g and MU1615::TN118g bacterial cells per
insect section.
AFB abundance as determined by number of bacilli within 50 random viewing fields at
1000× computed from a Most Probable Number (MPN) direct smear preparation. Y-axis,
number of bacterial cells; x- axis, days post infection. Head (A), raptorial arms (B),
thorax (C), salivary glands (D) and gut (E).
*significant difference between MU1615g, dark gray bars and MU1615::TN118g, light
gray bars.
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Figure 3.2: Scanning elecron micrographs of uninfected (top panel) and M. ulcerans
infected (bottom panel) belostomatids.
(A and D) Stylet; (B) tip of raptorial arm; (C and F) setae of raptorial arm of uninfected
insect; (E) rostrum of infected insect. Arrows indicate clusters adherent bacteria, 60
days p.i.
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Figure 3.3: Abundance of MU1615g in raptorial arms, gut and salivary glands.
Location of acid-fast (bright-field microscopy) and GFP-labeled (epiflourescence
microscopy) MU1615g in raptorial arms, gut and salivary glands of infected insects.
Raptorial arms at 1d (A, B) and 60d (C, D) post infection. Gut at 1d (E, F) and 60d (G,
H) post infection. Salivary glands at 1d (I, J) and 60d (K, L) post infection.
Arrows indicate clusters of acid fast and fluorescent bacilli respectively
Total magnification = 1000×
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Figure 3.4: Flow chart of experimenal design to analyze blow fly larvae exuviae for
the presence of M. ulcerans
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Figure 3.5: Presence of M. ulcerans in exuviae of maggots infected by belostomatids.
Ziehl Neelsen stain (A and C) and observation under a GFP filter (B and D), of maggot
exuviae collected from uninfected (A and B) and MU1615g infected (C and D)
belostomatid post feeding. Total magnification = 1000X. Arrows indicate clusters of acid
fast and fluorescent bacilli respectively.

64

Chapter 4: Experimental infection of Medaka (Oryzias latipes)
with Mycobacterium ulcerans: A model for transmission,
pathogenesis and toxicity to fish.
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4.1 Introduction
Naucorids and Belostomatids have been implicated as insect vectors of Buruli
ulcer. Both groups of insects are aggressive predaceous hemiptera, known to attack
and immobilize prey that may even be larger than them (40). Both insects are known
to consume small fish. Fish in Buruli ulcer endemic water bodies have been found
positive for the M. ulcerans DNA. About 90% of this evidence has relied on the
identification of M. ulcerans using primers designed for the insertion sequence IS2404
(10, 23). It has been shown, however, that IS2404 is not exclusive to M. ulcerans as
previously thought (35, 46). Other organisms within aquatic water bodies including
novel strains of Mycobacteria have also been found to be IS2404 positive. Recently, it
has also been shown by variable nucleotide tandem repeat typing that the DNA
isolated from most of the fish collected from endemic water bodies, identify novel
mycobacterial species and not M. ulcerans (46).
Mycobacteriosis in fish has been well documented over the years (8, 22, 31) with
the three most important pathogenic species being M. abscessus, M. fortuitum and M.
marinum. More recently however, outbreaks of mycobacteriosis have been reported in
various locations along the Mediterranean Sea and the Chesapeake Bay. These
infections have been attributed to novel mycobacterial strains including M. marinum
DL, M. pseudoshottsii, M. chesapeake and M. shottsii, which have all been isolated
and characterized (20, 34, 35, 42). One striking revelation is that some of these novel
strains possess a plasmid that encodes for variants of the virulent macrolide toxin,
mycolactone, similar to the mycolactone produced by M. ulcerans (33). Although
putative M. ulcerans DNA has been detected in fish, the ability of M. ulcerans to
colonize fish has not been determined experimentally. Based on this evidence we have
investigated the capability of M. ulcerans to produce an infection in Medaka (Oryzias
latipes).
Medaka are small (2-3 cm long by 0.5-1cm wide) oviparous fresh water fish native
to Asia and found primarily in Japan (38, 48). They are widely used as a laboratory
animal in biological fields, especially useful for studying developmental biology (27,
47). Medaka are omnivorous and can be maintained on a variety of synthetic diets,
water fleas, nauplia of brine shrimp, aquatic worms, dried unicellular green algae and
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large protozoa. The maximal survival lifespan of Medaka in undisturbed environments
is reported as 5 years (11), however under laboratory conditions, Medaka can live a
maximum of 1 year (38).
Almost all aspects of Medaka biology have been repeatedly studied and published.
Life-cycle, sexual behavior, spawning habits, embryological development, genetic
inheritance, pathology, feeding habits and ecology of the fish have been well
documented (11, 12,15). Subsequently, Medaka serves as a good model for the study
of human disease, because they have an immune response and genes similar to humans
(3). Medaka and human share 104 conserved systemic segments involving at least 3
orthologous gene pairs (27). In line with these research advances are a wide range of
resources including extensive databases in toxicology, molecular genetics, and an
existing transgenic line. Of particular importance is the See- through (ST) Medaka
which are devoid of most major pigments, allowing organs to be observed in living
individuals (45). This transgenic model has been used very successfully as a tractable
experimental model for tuberculosis pathogenesis, using Medaka as the host for M.
marinum 1218 (3). The M. marinum 1218 infection model can be manipulated to yield
either acute or chronic infection in a dose dependant manner. The chronic infection
model is similar pathogenically to M. tuberculosis infections in humans, resulting in
slow but progressive granuloma formation in the liver and kidney, as well as
inflammation of the spleen (3).
M. ulcerans causes a painless infection in humans and guinea pigs, characterized
by cell death via apoptosis with no apparent immune response (14). In anole lizards, it
produces three patterns of inflammatory response; a chronic granulomatous disease in
which acid fast bacilli are predominantly intracellular, encapsulated granuloma, or a
diffuse necrotizing granuloma in which most AFB are extracellular—similar to the
characteristic lesion found in human infections (25). In mice, M. ulcerans infection is
characterized by a persistent acute inflammatory response, necrosis, AFB resulting
from lysed phagocytic cells and nerve damage (16, 28).
The only reported association of M. ulcerans with fish has been the detection of
the bacterial DNA in fish collected from Buruli ulcer endemic areas. This is the first
study to address the ability of M. ulcerans to produce an active infection in fish and
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also provide information concerning the potential role of fish in the ecology of M.
ulcerans.

4.2 Results
4.2.1. M. ulcerans establishes systemic infection in Medaka
To determine the ability of M. ulcerans to establish an initial infection in Medaka,
infected fish were sacrificed 1 wk p.i., dissected and observed by fluorescent
microscopy for the green fluorescent marker on MU1615g and MU1615::Tn118g. We
observed that the heart, kidney and liver of the infected fish fluoresced green
compared to control (Fig 4.1 and data not shown) regardless of the dose of inocula
administered. To further substantiate our findings, the dissected organs were
homogenized and subjected to microscopy. Wet mounts of the homogenized organs
viewed under an epifluorescent microscope revealed the presence of Gfp expressing
bacteria (data not shown). Smears made from all dissected organs and stained with
Ziehl – Neelsen also revealed the presence of acid-fast bacilli (Tables 5.1and 4.2).
This observation was also comparable to the detection of bacteria DNA within the
organs via polymerase chain reaction (Table 4.1 and 4.2). The fact that bacteria were
present in all organs assayed suggests that M. ulcerans produces a systemic infection
in fish, similar to M. marinum strains.
4.2.2. M. ulcerans is both intracellular and extracellular in Medaka
In human and guinea pig infection, M. ulcerans is largely extracellular in the
lesions produced and does not form granulomas like other pathogenic mycobacterial
infections. To determine the histopathology of M. ulcerans in Medaka, infected fish
were sacrificed at 1, 8 and 23 wks p.i., fixed and stained with Ziehl-Neelsen and
hematoxylin and eosin. M. marinum 1218g and MMDL infected medaka were used as
positive controls. Negative control PBS-infected fish showed no presence of acid-fast
bacilli or pronounced inflammatory response at all time points (Fig 4.2 A and B).
MU1615 infected medaka were positive for very few intracellular acid-fast bacteria in
the kidney, spleen and liver (Fig. 4.2 C) and data not shown) but showed little
68

inflammatory response (Fig 4.2 D). There were pockets of extracellular bacteria
scattered in the guts of infected fish (Fig. 4.3 E and F). MU1615::Tn118g infected
Medaka showed scattered pockets of intracellular and extracellular acid-fast bacteria
diffuse inflammatory response in the kidneys and spleen (Fig 4.2 E and F, and data not
shown). As was expected in both strains of M. marinum infected Medaka, acid-fast
bacilli were both intracellular and extracellular (Fig 4.2 G, I and Fig. 4.3 C, E) with
loosely associated granuloma formation in 1218g (Fig. 4.2 H and Fig. 4.3 D) to well
organized granuloma in MMDL (Fig. 4.2 J and Fig. 4.3 F) (3, 44).
4.2.3. M. ulcerans is avirulent in Medaka compared to M. marinum
M. marinum is lethal to fish at concentrations above 105 cfu and produces chronic
granulomatous disease at concentrations below 103 cfu (3, 18, 39). To determine
whether M. ulcerans is pathogenic to Medaka, inocula was administered to the fish in
a dose dependent manner (102 – 108) and observed over time for the development of
disease and subsequently death. Even at the highest dose of 108, both MU1615g and
MU1615::Tn118g infected fish exhibited no gross signs of disease and survived up to
8 wks p.i. when they were voluntarily sacrificed (Fig 4.4B). At low doses of 102-104
M. ulcerans more than 70% infected fish survived up to 23 wks p.i, comparable to
PBS control fish (Fig 4.6 and 4.7). In stark contrast to the above, 1218g infected fish
all died before the end of the study and this occurred in a dose dependent manner.
Fifty percent of Medaka infected with 104 and 108 cfu all died by 2 wks pi and 1wk
p.i. respectively (Fig. 4.5A and 4.6). A similar observation was made for Medaka
infected with MMDL, however the time to death was delayed in these fish as compared
to M. marinum infected fish (Fig 4.5B and 4.6).
4.2.4. Mycolactone is not required for M. ulcerans persistence in Medaka
The pathogenicity of M. ulcerans has been attributed to the presence of the virulent
toxin mycolactone produced by the bacteria. To determine the effect of mycolactone
on the pathogenesis of M. ulcerans in Medaka, a mycolactone negative strain was
used. Fish infected with either the wild type or the mycolactone negative M. ulcerans
exhibited similar survival responses (Fig. 4.6, and data not shown). There was no
significant difference in the numbers of fish that were positive for either bacteria at all
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the time points assessed in this study (Tables 4.1 and 4.2). Even though Ziehl-Neelsen
stain revealed more visible bacteria in MU1615::Tn118g infected Medaka compared
to MU1615g Medaka in some cases, the amount of inflammatory response generated
was comparable (Fig 4.2 and 4.3). Both strains had pockets of bacteria within the guts
and few bacteria in the liver, heart and spleen
4.2.5. M. ulcerans does not appear to replicate within Medaka
M. marinum and M. fortuitum have been shown to replicate within both naturally
and artificially infected fish (37, 41). These bacteria can be successfully isolated from
infected fish due to the high numbers that result from colonization and replication. To
determine if M. ulcerans replicates within Medaka, we tried to culture the bacteria
from the organs of infected fish. However, our efforts were frustrated due to the
overgrowth of faster growing bacteria native to Medaka. We therefore determined the
increase in M. ulcerans DNA in infected Medaka over time using quantitative PCR
and primers designed to amplify the enoyl reductase gene of the mycolactone
producing plasmid. Our data suggests that there is no significant increase of M.
ulcerans within Medaka over time (Fig 4.8 and 4.9). Rather, there was a slight but
insignificant decrease in Medaka infected with 108 and 104 cfu MU1615g and 104 cfu
MU1615::Tn118g between 1 and 8 wks p.i. There was a significant decrease however
in the Medaka infected with 108 cfu of MU1615::Tn118g.

4.3. Discussion
M. marinum, the progenitor of M. ulcerans, is a well characterized fish pathogen
that successfully colonizes and replicates within infected fish (4, 9) and can be isolated
by culture from water and fish. Occasionally, M. marinum may cause human disease
when introduced via broken skin. The disease in man is characterized by granuloma
formation localized to the site of infection and histopathology reveals primarily
intracellular bacteria (8). On the other hand, M. ulcerans infection in man is localized
with the formation of lesions due to necrosis of the subcutaneous fat tissue and
bacteria are mostly extracellular (17, 19, 24). M. marinum has almost 98% sequence
identity with most genes in M. ulcerans, but lacks the mycolactone producing plasmid
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responsible for virulence. Also it appears that M. ulcerans is going through an
evolutionary bottle neck by the loss of metabolic and stress response genes suggestive
of the adaptation of the bacteria to a novel environmental niche (21).
Although the ecology and mode of transmission still remains unknown, the
association of M. ulcerans with slow moving water in all geographic areas where it has
been identified is the one major risk factor (1, 2, 5). M. ulcerans, however, cannot
survive in water (personal communication, Pamela Small) and hence needs a host or
reservoir within the environment where it can colonize and actively replicate. A wide
scale study of various environmental organisms within water bodies in M. ulcerans
endemic communities has revealed a high association of the bacterial DNA with
biofilm, water filtrate, and pseudophytes (glass slides) (46). M. ulcerans DNA has also
been identified in a wide range of aquatic invertebrates, of particular interest are
Naucorids and Belostomatids (26, 29, 46), and fish (10, 23), all collected from M.
ulcerans endemic water bodies. The diversity involved with the range of organisms
positive for DNA suggests the possibility of transfer of M. ulcerans in a very complex
food web within water bodies. As part of efforts to identify potential biological
reservoirs of M. ulcerans in the environment, we have established models for further
understanding the interactions between M. ulcerans and fish by the following: (i)
artificially infecting Japanese Medaka with M. ulcerans, (ii) determining the
pathogenicity of M. ulcerans in medaka, (iii) determining the role of mycolcatone in
Medaka infection and (iv) determining whether M. ulcerans can actively colonize and
replicate in Medaka. This is the first study to address the possibility of M. ulcerans to
survive and replicate in fish
Our data suggests that M. ulcerans is capable of establishing an early infection in
Medaka (Fig 4.1). We show by fluorescence microscopy that the infection is systemic
by 1 wk p.i., spreading to the organs following intraperitonial injection of the inocula.
We noticed that the Gfp signal was pronounced in MU1615::Tn118g infected fish
compared to MU1615g and this is because the mycolactone quenches the fluorescence
in the latter. Both wild type and mycolactone negative M. ulcerans can also be
detected intracellularly and extracellularly within the kidney, gut, heart, spleen and
liver of infected fish via acid-fast staining. These results are comparable to the early
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systematic spread of M. marinum in artificially infected fish following intraperitoneal
inoculation (3, 6, 13, 30, 32).
We also determined the pathology of M. ulcerans in medaka using increasing
doses of bacteria for inoclua. Whereas an inoculum of 106 cfu of M. marinum results
in an LD50 by 1 wk p.i. (3), medaka injected with 108 cfu of M. ulcerans, both wild
type and mycolactone negative mutant, survived the entire 8 weeks of study (Fig 4. 6).
Medaka infected with lower doses of M. marinum eventually develop a chronic
infection characterized by well organized granuloma formation in the kidneys, livers
and spleen, however there are no external signs of disease such as lesion formation. In
M. ulcerans infection, there is no granuloma formation but there is the presence of
scattered pockets of bacteria within the kidney, guts and peritoneum of infected fish.
There is also a lack of pronounced inflammatory response and the fish appear healthy
looking (Fig5.2). This observation may be different in other fish as hosts. For instance
in M. marinum infection of zebra fish and gold fish, even though low doses result in
chronic disease, infected fish develop lesions and appear bloated in comparison to
control (3, 30, 41). In addition to these observations, mycolactone does not appear to
confer additional virulence to M. ulcerans pathogenicity to Medaka. Our data shows
no statistically significant difference between the genome forming units of both strains
at 1, 8 and 23 wks p.i (Fig 4.8 and 4.9). Again, these results may be different in a
different breed of fish.
A key finding from this study is that M. ulcerans does not appear to replicate in
Medaka. Acid fast bacteria could be identified in fish sacrificed at 8 and 23 wks p.i.,
however, in comparison with M. marinum infected fish, there was no significant
increase in the number of bacilli observed. Since we were unable to culture back form
infected fish, we used PCR to determine increase in genome forming units of M.
ulcerans. Our data shows an insignificant decrease in both wild type and mycolactone
negative M. ulcerans (Fig 4.8 and 4.9). In order to avoid the bias conferred by the
different growth rates of M. ulcerans and M. marinum 1218, M. marinum DL was used
as a control. This fish pathogen produces mycolactone F, and is also classified as a
slow grower. M. marinum DL fish infected with 108 cfu all died by 10 days post
infection, and low dose infected medaka, although not showing outward signs of
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lesion formation and bloating, exhibited pronounced and well organized granuloma
formation in the kidneys, liver and, spleen (Fig 4.2 and 4.3). Pockets of intracellular
and extracellular acid fast bacilli were also identified within the granulomas. It is
unclear whether the resulting pathology is due to mycolactone F or other
immunogenic/virulent proteins in M. marinum DL. There have been conflicting reports
on the virulence of M.marinum DL in fish compared to wild type M. marinum (20, 43,
44).
Our findings are novel and relevant to the elucidation of potential environmental
reservoirs of M. ulcerans. To date, the association of M. ulcerans with fish has purely
been based on the identification of DNA using PCR and primers designed to amplify
the insertion sequence IS2404, previously thought to be unique to M. ulcerans (10,
23). Recent studies have revealed that this insertion sequence is present in other
organisms, particularly novel species of slow growing mycobacteria that also have the
mycolactone producing plasmid (35, 46). The latter discovery has also fueled the
discussions as to the ability of M. ulcerans to colonize fish. This study is the first of its
kind to describe the interactions that occur between M. ulcerans and fish. We cannot
rule out the possibility of fish being reservoirs in the transmission chain because it
appears that M. ulcerans persists in infected medaka, but we do not see any increase in
bacterial load over time. The infection may be transient in Medaka but have a different
characteristic is other laboratory fish models such as zebra fish and gold fish. It is
possible that those host systems may elucidate a finer differentiation of acute and
chronic infects on M. ulcerans, and possibly a role for mycolactone in pathogenicity.
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Table 4.1: Infected fish (104) sections positive for acid fast bacilli and bacterial DNA
(PCR) at 7 and 60dpi respectively

GUT

HEART

KIDNEY

LIVER

MU1615g

MU1615::Tn118g

MMDL

DAYS P.I.

7

60

7

60

7

60

Microscopy

3/4

4/4

3/4

4/4

4/4

4/4

PCR

1/4

4/4

2/4

2/4

4/4

4/4

Microscopy

0/4

1/4

1/4

2/4

1/4

4/4

PCR

2/4

2/4

2/4

1/4

0/4

4/4

Microscopy

3/4

2/4

2/4

3/4

1/4

4/4

PCR

3/4

2/4

3/4

2/4

1/4

4/4

Microscopy

1/4

3/4

1/4

4/4

3/4

4/4

PCR

1/4

4/4

2/4

1/4

2/4

4/4

3/4

4/4

3/4

4/4

4/4

4/4

PCR

4/4

4/4

3/4

2/4

4/4

4/4

Microscopy

0/4

2/4

0/4

4/4

1/4

4/4

PCR

1/4

2/4

1/4

4/4

0/4

4/4

CARCASS Microscopy

SPLEEN
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Table 4.2: Infected fish (108) sections positive for acid fast bacilli and bacterial DNA
(PCR) at 7 and 60dpi respectively

GUT

HEART

KIDNEY

LIVER

CARCASS

SPLEEN

MU1615g

MU1615::Tn118g

MMDL

DAYS P.I.

7

60

7

60

7

60

Microscopy

3/4

3/4

4/4

4/4

4/4

4/4

PCR

3/4

2/4

4/4

4/4

3/4

4/4

Microscopy

1/4

2/4

1/4

4/4

3/4

4/4

PCR

3/4

3/4

1/4

4/4

2/4

4/4

Microscopy

3/4

3/4

3/4

4/4

2/4

4/4

PCR

3/4

3/4

3/4

4/4

2/4

4/4

Microscopy

2/4

3/4

1/4

4/4

4/4

4/4

PCR

3/4

2/4

3/4

4/4

4/4

4/4

Microscopy

3/4

3/4

4/4

4/4

4/4

4/4

PCR

3/4

3/4

4/4

4/4

4/4

4/4

Microscopy

3/4

3/4

3/4

4/4

2/4

4/4

PCR

3/4

3/4

3/4

4/4

2/4

4/4
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Figure 4.1: Initial establishment of infection of Medaka by fluorescent microscopy.
Dissected organs from 108 cfu MU1615g (top panel) and MU1615::Tn118g (bottom
panel) infected medaka were examined for Gfp expressing bacteria 1 wk post-infection.
A, C, E and G – bright field; B, D, F and H – fluorescent filter. A, B, E and F - liver; C,
D, G and H – kidney.
Scale bars =10µm
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Figure 4.2: Representative histopathology of Medaka infected with 104 cfu of
different strains of mycobacteria 8 wks post-infection.
All sections were fixed and stained with Ziehl – Neelsen stain (left panels) and
hematoxylin and eosin stain (right panels). (A and B) PBS negative control. (C and D)
1218g infected Medaka showing loosely associated granuloma (D) with intracellular and
extracellular pockets of bacteria (C – arrow and inset). (E and F) MMDL infected
Medaka showing well organized granuloma with necrotic centers (F – arrow) surrounded
by bacteria. (G and H) MU1615g infected Medaka showing little inflammatory response
(H) with few intracellular bacteria (G- arrow and inset). (I and J) MU1615::Tn118g
infected Medaka showing diffuse inflammatory response (J) and scattered pockets of
intracellular and extracellular bacteria (I – arrow and inset). Total magnification, ×200 for
all panels and ×1000 for insets. Scale bars = 50 µm
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Figure 4.3: Mycobacteria strains produce systemic intracellular and extracellular
infection in Medaka.
Histopathology of sections fixed and stained with Ziehl – Neelsen (left panels) and
hematoxylin and eosin (right panels) for Medaka infected with 108 cfu. (A and B) Gut of
MU1615::Tn118g infected Medaka showing scattered extracellular bacteria (arrows). (C
and D) Liver of 1218g infected Medaka showing well organized granuloma (D – arrow)
surrounded by bacteria (C-arrow). (E and F) Gut of MU1615g infected Medaka showing
scattered extracellular bacteria (arrows). (G and H) Spleen of MMDL infected Medaka
showing diffuse granuloma (H-arrow) with mostly intracellular bacteria. Magnification,
×200 for all panels and ×1000 for insets. Scale bars = 50 µm
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Figure 4.4: Gross morphology of Medaka post infection.
(A) Medaka injected with 30µl of PBS (negative control) at 8 wks post infection.
(B) Medaka injected with 108 cfu MU1615g at 8 wks post-infection show no signs of
disease or lesions. Scale bars = 100mm
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Figure 4.5: Gross morphology of Medaka post infection.
(A) Medaka injected with 108 of 1218g at 4 wks post infection. (B) Medaka injected
with 108 cfu MMDL at 7 wks post-infection show signs of bloating. Scale bars =
100mm
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Figure 4.6: Percent survival of Medaka infected with 104 (A) and 108 (B) cfu of
different mycobacteria strains ( experimental design 2).
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Figure 5.7: Percent survival of Medaka infected with 104 cfu of MU1615g and
MU1615::Tn118 compared to control (experimental design 1)
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Figure 4.8: Mycobacterium ulcerans persists but does not appear to replicate in
Medaka (Experimental design 1).
Mean log genome forming units (gfu) of MU1615g and MU1615::Tn118g infected (104
cfu) Medaka at 1, 8 and 23 wks p.i for ER-PCR positive Medaka as determined by qPCR
using an internal probe for the ER gene. Data are means and standard deviations of the
values obtained from infected medaka. P>0.05 for both strains (Mann Whitney test).
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Figure 4.9: Mycobacterium ulcerans persists but does not appear to replicate in
Medaka (Experimental design 2).
Mean log genome forming units (GFU) of MU1615g and MU1615::Tn118g infected
Medaka at 1 and 8wks p.i for ER-PCR positive Medaka as determined by qPCR using an
internal probe for the ER gene. Data are means and standard deviations of the values
obtained from infected Medaka. P>0.05 for both strains (Mann Whitney test). R2 = 0.995
and 0.975 for MU1615g and MU1615::Tn118g respectively.
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Chapter 5: Fish monocytes as a model for understanding M.
ulcerans-host pathogenesis
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5.1 Introduction
The ability of mycobacteria to colonize a eukaryotic host involves a long history of
co-evolution and adaptation. In this process, the more rapid generation time of the
bacteria compared to the host has enabled bacteria in many cases to adapt to their hosts
without causing lethal infections. The hallmark symptom of mycobacterial infection
in humans, fish and laboratory animals is the formation of granulomas (6). Granuloma
formation is an immune mediated response used by the host to trap pathogens and
other foreign substances. The primary cells involved in granuloma formation in
mycobacterial infections are macrophages, but other cells such as lymphocytes,
fibroblasts and bacteria are also important (1). The classical model of granuloma
formation has been perceived as a host-protective event to prevent the spread of the
infection (32, 39). However, recent data suggests that granulomas also play a role in
expanding bacterial infection (7). Employing both in vitro and in vitro assays,
researchers have shown that M. leprae, M .tuberculosis, M. avium and M. marinum
can enter macrophages and subsequently replicate within phagosomes by interrupting
phago-lysosome formation (4, 8, 13, 26 30).
M. marinum infection in fish has been widely used as a surrogate model for
understanding the host-pathogen interactions between M. tuberculosis and its human
host (3, 5, 7, 29, 39). It is pathogenic mycobacteria, closely related to M. tuberculosis
with a much shorter generation time and has been used successfully in both in vivo and
in vitro experiments. Since fish are natural hosts for M. marinum infection, their
macrophages have been used to further tease out specific interactions that occur during
acute and chronic infection (10, 15, 41). Macrophages are ubiquitously distributed in
tissue and play a key role in the early immune response as well as in adaptive
immunity. They are key mediators of the inflammatory response both in acute and
chronic infection.
In humans, most M. marinum infections are cutaneous because M. marinum like
M. ulcerans has a restricted low temperature growth requirement. M. marinum is very
closely related to M. ulcerans and is thought to represent the ancestral line from which
M. ulcerans evolved. There is 98% sequence identity of the 16SrRNA genes from M.
marinum and M. ulcerans, and equally high homology between housekeeping and
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structural genes from the two species (22, 23, 24, 31, 37, 38). With the ongoing search
for the environmental reservoir of M. ulcerans and the phylogenetic relationship
between M. marinum and M. ulcerans, the question has been asked whether fish can
be a candidate involved in the transmission process or provide an ampilying reservoir
in the environment. There have been reports of potential of M. ulcerans DNA in fish.
Identification of M. ulcerans DNA have been based on identification of an insertion
sequence IS2404 in DNA extracted from fish collected in Buruli ulcer endemic areas
(9). It has been shown recently that the IS2404 insertion sequence is not unique to M.
ulcerans and is found in other organisms as well in other mycolactone producing
mycobacteria which cause infection in fish and frogs. In this work we have shown
experimentally that M.ulcerans does not replicate or cause disease in fish. M. ulcerans
strains are believed to have evolved from M. marinum through reductive evolution
(22, 23, 24, 32). Though through evolution, loss of genes makes M. ulcerans no
longer able to infect fish, acquisition of mycolactone cannot compensate for this (37,
38). This raises two hypotheses why M. ulcerans does not colonize fish; (i) because
mycolactone is not toxic for fish cells or (ii) because the genome reduction has
resulted in loss of genes necessary for pathogenesis in fish. We have tested the effects
of mycolactone on fish cells to address the first hypothesis.
Many models have been developed for studying the pathogenesis of M. ulceranss
including guinea pigs, mice, bats, armadillos and anole lizards. The best disease
model for understanding M. ulcerans pathogenesis is a guinea pig dermal model, in
which lesions develop as a result of mycolactone secreted by largely extracellular
bacteria (17, 18, 19, 20, 34). M. ulcerans causes a painless infection in humans and
guinea pigs, characterized by cell death via apoptosis with no apparent immune
response (17). In anole lizards, it produces three patterns of inflammatory response; a
chronic granulomatous disease in which acid fast bacilli are predominantly
intracellular, encapsulated granuloma, or a diffuse necrotizing granuloma in which
most AFB are extracellular—similar to the characteristic lesion found in human
infections (25). In mice, M. ulcerans infection is characterized by a persistent acute
inflammatory response, necrosis, AFB resulting from lysed phagocytic cells and nerve
damage (18, 27).
93

We have developed an in vitro model for understanding M. ulcerans pathogenesis
as a result of mycolactone using gold fish (Cyprinus carpio) macrophages (CLC). This
cell line has been well characterized (15) and is used as a model for mycobacterial
host-pathogen interations (10). The cell line has an optimal growth temperature of
28°C, which is ideal for M. ulcerans growth. It has been shown that M. marinum can
enter and replicate efficiently in CLC cells whiles M. smegmatis is killed
intracellularly (10). We used acetone solubule lipids (ASLs) of 3 different congeners
of mycolcatone; A/B produced by the African and Malaysian strains of M. ulcerans, E
produced by M. liflandii which cause disease in frogs and F produced by M. marinum
DL 240490 and M. pseudoshotsii which causes disease in fish. Acetone solubule
lipids extracted from these mycobacteria are described as partially purified
mycolactone and the sole activity of these lipids is due to mycolactone (16).This is the
first study to address whether M. ulcerans and mycolactone are pathogenic to fish cells
in vitro.

5.2 Results
5.2.1. Mycolactone is cytotoxic to CLC cells in vitro
The cytotoxic effects of different congeners of mycolactone have been described for a
variety of cultured cells including mouse fibroblasts and human neutrophils (2, 16, 17,
31, 34, 35). Mycolactone cytotoxicity is characterized by rapid necrosis at concentrations
above 1 µg/ml within 4 h and delayed apoptosis at concentrations as low as 1ng/ml
within 24 h. To determine the effect of mycolactone on CLC cells, acetone soluble lipids
from MU1615, MMDL and XL5 was added in a dose dependent manner to a semiconfluent layer of CLC cells and observed microscopically for their distinct phenotypes.
At concentrations above 10µg/ml, mycolactone A/B treated cells were visibly rounded
and swollen by 24 h p.i. compared to cells treated with an ethanol control. This
phenotype is significant of necrosis. At 10ng, cells treated with mycolactone A/B had
mostly lost the confluent monlayer appeared apoptotic (Fig. 5.1). By 48 h post treatment,
the cell monolayer had completely detached. Cytotoxic effects were also observed with
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mycolactone F and E treated cells, however, the phenotype differed slightly from
mycolactone A/B treated cells. At concentrations of 10µg and above, mycolactone E and
F treated cells appeared mostly apoptotic with condensed nuclei with loss of cell structure
(Fig. 5.1). These observations were also made for cells treated with mycolactone
concentrations below 100ng, but were delayed. Also, at low concentrations of
mycolactone E and F treated cells, some cells were able to regain their morphology after
48 h.
To determine the mechanism of mycolactone – mediated cell death by mycolactones
A/B, E and F, we added acetone soluble lipids from MU1615, XL5 and MMDL to a
semi-confluent layer of CLC cells in a dose dependent manner and tested for the ability
to produce apoptosis and necrosis. Apoptosis is characterized by nucleosome enrichment
and clearing of the cytoplasm, and was quantified using an ELISA kit at 24h post
treatment with mycolactone. There was a dose dependent apoptotic effect on
mycolactone A/B and F treated cells (Fig. 5.2). At concentrations of 100µg and 10µg,
mycolactone A/B and F treated cells were at least 2-fold more apoptotic than
mycolactone E treated cells. At the lowest concentration of 10ng there was limited
apoptosis with no significant difference between the congener of mycolactone used.
Mycolactone E treated cells did not appear to have marked differences in apoptosis
regardless of the concentration of mycolactone used.
Necrosis of cells treated with mycolactone is characterized by cell rounding and
swelling followed by membrane permeabilization and cell lysis. This phenotype was
quantified by the release of LDH during cell lysis after treatment with mycolactone for 24
h. Mycolactone A/B treated cells exhibited the highest amount of apoptosis at 100µg and
this amount significantly decreased with decreasing doses of mycolactone. Conversely,
both mycolactone E and F treated cells releases significantly low amounts of LDH at
100µg. At all other concentrations, there was no significant difference between the
amounts of apoptotic cells regardless of the mycolactone congener used. These results
suggest that mycolactone A/B – mediated cell death is via both apoptosis and necrosis
whereas cell death by mycolactones E and F is mostly mediated via apoptosis. It is also
evident from these results that mycolactone A/B exhibits a more potent effect on CLC
cells compared to mycolactone E and F.
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5.3 Discussion

The activity of mycolactone A/B on human macrophage and neutrophils, and mouse
macrophage and fibroblasts has been investigated (2, 16, 30). The hallmark cytotoxic
phenotypes include cell rounding and swelling with subsequent cell lysis at high
concentrations and eccentric condensed nuclei with cleared cytoplasms at low
concentrations.

Further analysis shows that mycolactone causes cell death by both

necrosis and apoptosis. These events explain to a large extent the localization of M.
ulcerans at the site of infection, the non-systematic nature of the disease and the
observation of extracellular bacilli in histopathological sections of fixed lesion tissue. In
earlier studies we find that M. ulcerans does not cause disease in fish. Conversely, M.
marinum DL causes disease in fish and makes mycolactone F whilst M. liflandii causes
disease in frogs and makes mycolactone E. We are uncertain as to whether the lack of
disease is due to the loss of genes in M. ulcerans or that mycolactone is not cytotoxic to
fish cells. In order to understand the pathogenic potential of M. ulcerans to fish, we have
investigated the toxicity of mycolactone for fish cells using CLC macrophages from
goldfish. This model system has been used for understanding M. marinum pathogenesis
as a surrogate model for M. tuberculosis pathogenesis (10). Studies of the immune
defense mechanisms of fish have shown significant similarity with those of mammalian
systems (11, 12). Fish have B and T – like lymphocytes, non specific cytotoxic cells
(NK-like cells) and phagocytic cells including macrophages (11, 12). The latter have
been shown to be involved in first line defenses just like in mammalian systems and are
ubiquitously distributed throughout the fish (40).
Our data suggests that all three congeners of mycolatone are cytotoxic to CLC cells in
vitro. The potency of mycolactone E and F appear to be reduced compared to that of
mycolactone A/B. These results have been corroborated by a previous study which also
showed a fold decrease in potency of mycolactone F on mouse fibrolasts (L929 cells) as
compared to mycolactone A/B (31). Structurally, all three mycolactone make the same
core but differ slightly in the side chain (28). Mycolactone A/B has the longest side chain
of the three (15C) and has a hydroxyl group on carbon 12 that is absent in the other two
congeners. Mycolatone F has the shortest side chain (13C), whilst mycolactone E has a
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14 carbon side chain. The differences in the side chains have been associated with the
level of potency of the mycolactones in their respective hosts. However, no study has
been done to understand the relative degree of toxicity of each mycolactone within the
same host.
We also have characterized the mechanism of CLC cell death due to mycolactone. We
show that cell- mediated death due to mycolactone A/B is mostly by necrosis at high
concentrations and apoptosis at low concentrations and is dose dependent. Again this
phenomenon has been described for other cell types and our results are in concordance
with previous observations (2, 16, 31). These results further support localization of the
infection and the subsequent lack of dissemination because all the first line immune
defense cells that take up the bacteria upon infection are killed by mycolactone. In
contrast, we have observed that cell - mediated death due to mycolactones E and F is
characterized largely by apoptosis. This might explain why M. marinum DL, the strain
that makes mycolactone F, is able to cause disease in fish by the formation of granuloma.
These observations support the fact that mycolactone A/B is the most potent congener of
mycolactone.
In conclusion, we have investigated virulence of M. ulcerans for fish in two ways; (i) a
fish model in vivo and (ii) a cell model in vitro. Studies conducted in our lab suggest that
M. ulcerans may not be pathogenic in fish (this work). In contrast we have evidence that
CLC macrophages from goldfish are susceptible to mycolactones. If mycolactone is made
by M. ulcerans in vivo in fish, early cytotoxic events due to mycolactone A/B can alter
the ability of M. ulcerans to replicate within fish macrophages and hence the inability of
M. ulcerans to produce disease in fish. In contrast M. marinum DL, which makes
mycolacttone F causes disease in fish. It is possible that the later has evolved in fish and
has maintained it tropism for fish cells whilst M. ulcerans has evolved in other hosts and
has subsequently lost its abitllity to colonize fish.
Other immune cells may also confer a supportive role in containing the infection
caused by M. ulcerans. Generally, mycobacterial species are capable of being
internalized by macrophages and epithelial cells, however, non-pathogenic strains are
readily killed by the cell defense mechanisms (21, 34, 35). Pathogenic species on the
other hand can overcome these defense mechanisms and subsequently replicate within
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infected cells (26, 29). It is possible that the absence of disease in M. ulcerans infected
fish could be due to the lesions in the chromosome of M. ulcerans created during its
reductive evolution from M. marinum. Another possibility is that mycolactone is
regulated in vivo and is not being made by M. ulcerans in fish, or if it is being made, the
phagocytic cells are immediately killed by mycolactone and hence the bacteria cannot
replicate and are subsequently killed. In human and guinea pig infections where
mycolactone is being actively secreted, there are both apoptotic and necrotic cells. In
histological sections of M. ulcerans infected Medaka, this observation is absent and there
is very little influx of immune cells in areas where bacteria are found, suggestive of the
absence of mycolactone.
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Figure 5.1: Concentration dependent cytotoxicity of different congeners of
mycolactone on CLC cells.
Magnification ×200.
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Figure 5.2: Cytotoxicity of mycolactone measured by LDH release and nucleosome
enrichment.
(A) Culture supernatants were collected from wells containing CLC cells 4 h after
treatment with mycolactone and the amount of LDH was measured using a Cytotox 96
assay kit (Promega). Data are means and standard deviations of the values obtained from
triplicate samples; P>0.05 for all concentrations (Student’s t test). (B) Apoptosis was
assessed at 24 h with the cell death detection enzyme-linked immunosorbent assay kit
(Roche) and expressed as fold enrichment of nucleosomes. Data are means and standard
deviations of the values obtained from triplicate samples; P>0.05 for all concentrations
(Student’s t test).
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Chapter 6: Identification of Native Insect Bacteria Using
culture and culture independent methods
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6.1 Introduction
Naucoridae and Belostomatidae are families of predaceous aquatic insects that
belong to the order Hemiptera, also known as true bugs. They are found all over the
world and there are few habitats without Hemiptera adapted to living there (9). Naucorids
and Belostomatids thrive within a wide range of temperatures and climate conditions.
The order is morphologically diverse. However all hemiptera have large compound eyes,
four or five segmented antennae and have mouthparts that have been adapted for piercing
or sucking. Their mandibles and maxillae are modified as needle-like stylets with two
canals; one for delivering saliva and one for sucking fluid (11). The predatory suborders,
to which Naucorids and Belostomatids belong, have well developed raptorial arms with
which they grab and immobilize their prey prior to injection of paralyzing saliva.
Naucorids are most common in the tropics and there are about 150 described
species (22). The most common genera include Ambrysus, Aphelocherirus, Laccocoris,
Pelocoris and Naucoris of which the latter is dominant in Africa (23). There are
approximately 200 described species of belostomatids and the most common genera are
Belostoma, Abedus, Lethocerus and Diplonychus. The latter is dominant in Africa and
prefers to live in the vegetative areas of stagnant water bodies. Previous work published
by Portaels et al (18), found African naucorids and belostomatids among other aquatic
non-predaceous insects to be positive for Mycobacterium. ulcerans DNA. To support this
finding, Marsollier et al. carried out studies on naïve Naucorids collected in France,
where he infected these insects in the laboratory with M. ulcerans and followed the
infection over a period of 90 days (15). He showed that the bacteria successfully
colonized the insects, causing no growth impairment throughout this period.
Insects are known to harbor a wide range of microbiota primarily in the gut and
this property is useful in identifying various classes of insect- symbiont relationships (7,
8). The associations between these microbes and insects may either be parasitic, where
the microbes benefit at the expense of the insect, mutualistic or symbiotic where both
insect and bacteria benefit or none of the parties are harmed respectively. In the later
cases, the microbes help in digestion and sequestering of nutrient for the insects that are
on sub-optimal diets (2, 5, 6, 20). Just as the case is in humans, indigenous insect bacteria
also play a role in withstanding the colonization of the gut by non-indigenous species
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including pathogens (3, 7, 21). Insect bacteria are also known to play an important role in
the generation or suppression of immune responses in the insects. In mosquitoes for
instance, there is a link between the reduction in gut bacteria and increased production of
Plasmodium oocysts (2). There are other multitrophic interactions that exist between
insects and their environment as a result of their indigenous microbiota. The microbes
within the gut of insects have the ability to adapt rapidly to changes in the insect diet and
infection by non-indigenous bacteria. This is reflected in changes in enzyme profiles and
alterations in population dynamics following feeding (3, 4).
Approximately 90% of insect-associated microbes have not been successfully
cultured directly from their natural environments (1). This may be due to host specificity
or the degree to which growth of these organisms is restricted. This problem can be
overcome by the use of genomic approaches where organisms are identified at the DNA
or RNA level (13, 14). These molecular methods are sufficiently accurate and are much
less time consuming than attempts at culture. With this in mind, analysis of the normal
flora of the naucorids and belostomatids was undertaken to provide important
information on the potential interactions that might occur as a result of introduction of M.
ulcerans to the insects. Information from these studies is also useful for developing
techniques to suppress the growth of the insect normal flora in order to obtain M.
ulcerans positive cultures. Finally identification of normal insect flora could provide a
background for studying interactions between insect normal flora and M. ulcerans.

6.2 Results
6.2.1. Isolation and characterization of bacterial Isolates
For the isolation and identification of bacteria native to belostomatids and
naucorids, serial dilutions of insect section homogenates were plated on LB and M7H9
media. LB media was used because it is rich in proteins. M7H9 mycobacterial media on
the other hand is much less nutrient rich and was used to isolate potential native insect
bacteria that might interfere with isolation of M. ulcerans. Bacterial colonies that formed
in 24 – 48 h of incubation at 37°C were passaged on media up to three times in order to
obtain pure cultures. The resulting isolates were subjected to antibiotic susceptibility tests
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and growth on selective and differential media. Almost all of the bacteria found on and
within the insects were gram negative (Table 6.1). No mycobacteria were isolated. The
majority of isolates were Enterobacteriace cultured from the guts and thoraces of the
insects. The distribution of the isolated bacteria species appeared to be random and there
were many instances where bacteria with similar colony morphology were present in
more than one tissue. The isolates that occurred in high frequency were Salmonella sp.,
Klebsiella sp., and Proteus sp. The only gram positive bacterium isolated was Bacillus
sp. from the gut and raptoral arms of the insects.Approximately 90% of the isolates were
resistant to ampicillin, penicillin, clindamycin and sulphonamides (Table 6.2). The most
antibiotic resistant strain isolated was Burkholderia sp. This isolate was susceptible only
to ciprofloxacin and chloramphenicol.
6.2.2. Identification of bacterial strains using 16S rRNA sequencing
In order to identify bacterial species that might be missed using culture dependent
methods, the 16S ribosomal RNA was amplified directly from DNA isolated from the
insect homogenates. Bacterial strains identified in Belostomatid homogenates are shown
in Fig. 6.1 whilst those identified in Naucorid homogenates are shown in Fig. 6.2.
Consistent with results from the culture dependent identification, about 80% of the
sequenced bacteria had G+C contents between 40-50%, indicative of members of the
family Enterobacteriaceae. In belostomatids, the most abundant bacterial strains were
Klebsiella pneumoniae and Bukholderia cepacia (Fig 6.1). In the naucorids, there were
no dominant bacterial strains however about 80% of the bacteria identified were
enterobacteriaceae. There were 2 genera of gram positive bacteria; Bacillus sp. and
Geobacillus sp. identified (Fig. 6.2). Common to both insects were Klebsiella
pneumoniae, Serratia marscenses and Burkholderia sp.
We assessed the percentage abundance of each bacterial species identified by anatomical
section of the insects. As was expected the guts of both Naucorids and Belostomatids had
the highest bacterial diversity compared to the raptoral arms and salivary glands with at
least 30% of insects being positive for more than 4 different types of bacteria (Fig 6.3).
The most abundant strains isolated from the guts were Proteus sp., Pseudomonas sp. and
Comamonas sp.The thoraces also had a significant amount of bacterial diversity with the
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most abundant species identified being Klebsiella pneumonia and Proteus vulgaris. The
salivary glands and raptoral arms had the least amount of bacterial diversity with only
10% of insect being positive for the identified bacteria in most cases.
6.2.3. Phylogenetic diversity
Phylogenetic diversity of bacteria identified by culture and by 16S rRNA
sequencing was investigated. Bacteria were grouped according to phylotypes and the
frequency of each occurring phylotype was scored against the total number of bacterial
species identified (Fig. 4.4). The gamma proteobacteria phylotype occurred with the
highest frequency among cultured isolates; 96%, and 90% for Naucorids and
Belostomatids respectively. Among the bacterial strains identified by 16SrRNA
sequencing, 90% and 50% respectively for Belostomatids and Naucorids were gamma
proteobacteria. Delta proteobacteria were only identified among the sequenced isolates ad
at low frequencies; 5% and 8% respectively for Belsotomatids and Naucorids.
Aproximately 10% firmicutes were identified by both culture and sequencing. There was
however no firmicute among the bacterial strains identified in Belsotomatids by
sequencing. Beta proteobacteria were identified at a low frequency (~10%) by both
sequencing and cutlture except among cultured bacterial isolates from Naucorids.
6.3 Discussion
In this study, the bacterial prevalence and diversity within belostomatids and
naucorids was investigated using both culture dependent and culture independent
methods. A broader diversity was noted among the culture independent method. This is
not surprising as approximately 90% of bacteria have not yet been cultured (13, 17).
Using classical microbiological tests, we were able to identify 45 different bacterial
isolates to the genus level. Among these were largely members of the family
Enterobacteriaceae in all the sections of the insects assayed, with the most frequent
genera being Salmonella, Klebsiella and Proteus. All three genera have been repeatedly
identified in similar studies (6, 10, 19, 20) by culture. Most of the the isolates were
resistant to at least one antibiotic and this may be explained by the high rate of horizontal
gene transfer of antibiotic resistance between bacteria found in the guts of insects (12). A
significant level of resistance was noticed for amplicillin and penicillin. These antibiotics
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are beta lactams that are effective mostly against gram positive bacteria and some gram
negative bacteria. These results corroborate the observation that about 90% of the isolates
were gram negative. The most resistant strain isolated was Burkholderia cepacia.
Burkholderia sp. are ubiquitous environmental bacteria with important pathogenic
species associated with cystic fibrosis (1). They are also well known for their resistance
to a wide variety of antibiotics (16). We were unable to identify the bacteria to the
species level, however, further biochemical testing can readily differentiate between
pathogenic and non-pathogenic genera identified in this study for example Salmonella sp.
The bacterial strains identified via 16S rRNA sequencing also revealed a high
frequency for members of the family Enterobacteriaceae. Similar to data obtained from
using culture dependent methods, there was little difference between genera of bacteria
identified on different anatomical sections of the insects. The most frequent bacteria
identified in belostomatids were Klebsiella pnuemoniae and Burkholderia cepacia whilst
there was no dominant genus among naucorids. As was expected, the guts of both insects
had the most diversity of bacteria compared to other sections analyzed. Surprisingly, at
least 3 salivary glands of the insects had more than one type of bacteria isolated by both
culture dependent and culture independent methods. This organ is relatively sterile in
most insects and M. ulcerans has been recovered via culture from artificially infected
naucorids due to this reason (15).
Other genera of interest identified in this study were, Acinetobacter, Serratia and
Comamonas which are both associated with human disease and also ubiquitous in the
environment. All three above genera have been identified in insects (7, 6, 8, 13). We were
unable to isolate many of gram positive bacteria by either culture dependent or culture
independent methods. In other studies, gram positive bacteria, especially members of the
family Enterococcus and Streptococcus, which are somewhat fastidious bacteria, have
been frequently isolated from the guts of insects (6, 19). The media used in initial
isolation of bacteria plays an important role in the bacteria eventually isolated. For
instance blood agar is used mostly in to isolation of gram positive bacteria. In our study,
the use of LB and M7H9 may have accounted for the high amount of gram negative
bacteria isolated. There may have been a selective bias for interesting colonies during the
initial screening of plates. For the culture independent method, the 16S rRNA primers
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used were considered universal for bacteria, however, they may be biased to amplify only
certain DNA sequences than others. This discrepancy may be also be explained by the
fact that naucorids and belostomatids are aquatic insects and may have a different
community of native bacteria.
We also described the phylotype diversity of bacteria present in Belostomatids
and Naucorids. The gamma proteobacteria were the most abundant phylotype and this is
true for other studies (14, 19, 21). The beta and delta proteobacteria were also represented
in small amounts, however, it was surprising that no actinobacteria were identified in this
study. M. ulcerans is a member of the actinobacteria phylum and their DNA has been
identified in a small percentage of belostomatids and naucorids (18, 27). Evident from
this study are the differences between bacteria identified by culture independent and
culture dependent methods for the same sample. All four phylotypes identified in this
study were represented in bacterial strains identified in Naucorids by 16SrRNA
sequencing whereas only two phlyotypes were represented by culture dependent
methods.
In conclusion, our data shows that there is significant native flora within
belostomatids and naucorids. Of importance is the fact that almost 90% of the isolated
bacteria grew well on M7H9 mycobacterial media and there will be possible interference
with the isolation of M. ulcerans from infected belostomatids or naucorids. Also most of
these bacteria have acquired significant resistance to most mainstream antibiotics. What
remains unknown is whether these native bacteria confer any selective advantage or
disadvantage to artificially introduced M. ulcerans to colonize and replicate within the
insects.
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Table 6.1: Identification of bacterial strains using culture dependent methods

Identification

Growth

of section

on LB

Growth

Gram

Growth

on

stain

on TSI

M7H9

Growth

Gelatin

on

hydrolysis

Citrate

SIM

Urease

ID

(motility/sulfur
production/indole)

Gut 1

yes

yes

-

A/A/-

+

-

-/-/-

-

Enterobacter

Gut 2

yes

no

-

n/a

+

+

n/a

+

Burkholderia

Gut 3

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

Gut 4

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

Gut 6

yes

no

-

n/a

+

+

n/a

+

Burkholderia

Gut 7

yes

yes

-

A/A/+

-

+

+/-/+

-

E.coli

Gut 8

yes

yes

+

n/a

+

-

n/a

+

Bacillus

Gut 9

yes

yes

-

A/A/+

-

-

+/-/+

-

E.coli

Gut 10

yes

yes

-

A/A/+

-

-

+/-/+

-

E.coli

Gut 11

yes

yes

+

n/a

-

-

n/a

+

Bacillus

Gut 12

yes

yes

-

K/K/-

-

-

-/-/-

-

Shigella

FA 1

yes

yes

-

A/A/-

+

+

-/+/-

+

Serratia

FA 2

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

FA 3

yes

yes

-

A/A/+

-

-

+/-/+

-

E.coli

FA 5

yes

yes

-

A/A/-

+

+

-/+/-

+

Serratia

FA 6

yes

yes

-

K/K/-

-

-

-/-/-

-

Shigella

SG 2

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

SG 3

yes

yes

-

A/K/+

+

-

+/+/-

+

Citrobacter

SG 4

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

SG 5

yes

yes

-

A/A/-

+

+

-/+/-

+

Serratia

SG 6

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

SG 7

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

SG 8

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

Tho 1

yes

yes

-

A/A/-

+

+

-/+/-

+

Serratia

Tho 2

yes

yes

-

A/K/+

+

-

+/+/-

+

Citrobacter

Gut 5a

yes

yes

-

A/A/-

+

-

-/-/-

+

Klebsiella

Gut 5b

yes

yes

-

A/A/+

-

-

+/-/+

-

E.coli

Gut 6a

yes

yes

-

K/K/-

-

-

-/-/-

+

Shigella

Gut 6b

yes

yes

-

A/A/+

-

-

+/+/+

+

Proteus

FA 4a

yes

yes

-

A/A/-

+

-

-/-/-

+

Klebsiella

FA 4b

yes

yes

-

A/A/-

+

-

-/-/-

-

Enterobacter

FA 7a

yes

yes

+

n/a

+

-

n/a

+

Bacillus

FA 7b

yes

yes

-

A/A/-

+

+

-/+/-

+

Serratia

SG1a

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

SG1b

yes

yes

-

A/A/-

+

-

-/-/-

+

Klebsiella

FA7aC

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

FA7aY

yes

yes

-

A/A/+

-

-

+/+/+

+

Proteus

Gut5bp

yes

yes

-

A/A/-

+

-

-/-/-

+

Klesbsiella
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Identification

Growth

of section

on LB

Growth

Gram

Growth

on

stain

on TSI

M7H9

Growth

Gelatin

on

hydrolysis

Citrate

SIM

Urease

ID

(motility/sulfur
production/indole)

Gut5bs

yes

yes

-

A/A/-

+

-

-/-/-

-

Enterobacter

SG1aY

yes

yes

-

A/K/+

+

-

+/+/-

+

Citrobacter

SG1aC

yes

no

-

A/K/+

+

-

+/+/-

+

Salmonella

SG4COL

yes

yes

-

A/A/+

-

-

+/+/+

+

Proteus

SG4SWA

yes

yes

-

A/K/+

+

-

+/+/-

+

Salmonella

SG8Y

yes

yes

-

A/A/+

-

-

+/+/+

+

Proteus

SG8Ca

yes

yes

-

A/A/+

-

-

+/+/+

+

Proteus

SG8Cb

yes

no

-

A/A/-

+

-

-/-/-

+

Klebsiella
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Table 6.2: Antibiotic testing of bacterial strains isolated using culture dependent methods
Identification
of section
Gut 1

AM10a

CB100

P10

GM10

S10

E15

TE30

CIP

C30

CC2

SSS20

AN30

ID

0

25

0

21

20

0

0

35

25

0

0

27

Enterobacter

Gut 2

0

0

0

0

0

0

16

35

25

0

0

20

Burkholderia

Gut 3

0

0

0

11

20

14

14

40

25

0

0

21

Salmonella

Gut 4

0

0

0

13

19

12

0

32

25

0

0

21

Salmonella

Gut 6

0

0

0

0

0

11

20

32

25

0

0

21

Burkholderia

Gut 7

0

30

0

20

25

31

0

34

20

0

0

34

E.coli

Gut 8

0

30

0

25

12

0

0

40

15

0

0

21

Bacillus

Gut 9

0

27

0

31

24

32

0

40

21

0

0

32

E.coli

Gut 10

0

30

0

26

25

31

21

44

22

0

0

30

E.coli

Gut 11

0

30

0

24

15

0

0

43

16

0

0

25

Bacillus

Gut 12

0

25

0

30

31

0

15

32

25

0

0

32

Shigella

FA 1

0

0

0

33

30

0

12

45

25

0

0

21

Serratia

FA 2

0

0

0

10

21

0

18

45

25

0

0

20

Salmonella

FA 3

0

27

0

31

25

27

0

45

23

0

0

33

E.coli

FA 5

0

23

0

24

17

0

0

42

24

0

0

21

Serratia

FA 6

0

25

0

30

22

0

21

40

25

0

0

25

Shigella

SG 2

0

0

0

25

15

12

12

40

25

0

0

30

Salmonella

SG 3

0

30

0

23

23

0

0

44

26

0

0

31

Citrobacter

SG 4

0

0

0

15

22

10

12

43

23

0

0

27

Salmonella

SG 5

0

0

0

22

21

0

0

41

23

0

0

22

Serratia

SG 6

0

0

0

11

18

11

21

40

25

0

0

25

Salmonella

SG 7

0

0

0

12

18

14

10

32

25

0

0

23

Salmonella

SG 8

0

0

0

11

20

12

6

35

25

0

0

21

Salmonella
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Identification
of section
Tho 1

AM10a

CB100

P10

GM10

S10

E15

TE30

CIP

C30

CC2

SSS20

AN30

ID

0

0

0

23

21

0

0

35

25

0

0

33

Serratia

Tho 2

0

27

0

25

14

0

0

43

21

0

0

33

Citrobacter

Gut 5a

0

30

0

17

21

0

11

42

23

0

0

24

Klebsiella

Gut 5b

0

26

0

22

24

26

12

40

22

0

0

27

E.coli

Gut 6a

0

24

0

30

26

0

20

38

25

0

0

5

Shigella

Gut 6b

0

30

0

25

21

0

10

37

24

0

0

32

Proteus

FA 4a

0

24

0

24

21

0

12

41

23

0

0

21

Klebsiella

FA 4b

0

25

0

21

25

0

0

39

24

0

0

23

Enterobacter

FA 7a

0

23

0

23

22

0

0

40

25

0

0

30

Bacillus

FA 7b

0

0

0

31

21

0

0

41

25

0

0

2

Serratia

SG1a

0

0

0

12

19

12

21

44

21

0

0

25

Salmonella

SG1b

0

25

0

26

21

0

18

44

20

0

0

27

Klebsiella

FA7aC

0

0

0

10

25

12

12

45

25

0

0

24

Salmonella

FA7aY

0

24

0

23

22

0

11

45

24

0

0

31

Proteus

Gut5bp

0

25

0

33

21

0

12

45

23

0

0

26

Klesbsiella

Gut5bs

0

25

0

23

20

0

0

45

23

0

0

21

Enterobacter

SG1aY

0

30

0

24

22

0

0

42

25

0

0

24

Citrobacter

SG1aC

0

0

0

12

21

12

15

40

21

0

0

23

Salmonella

SG4COL

0

24

0

24

22

0

12

40

25

0

0

30

Proteus

SG4SWA

0

0

0

20

21

14

21

42

25

0

0

26

Salmonella

SG8Y

0

25

0

26

25

0

10

38

25

0

0

31

Proteus

SG8Ca

0

24

0

12

24

0

9

39

24

0

0

33

Proteus

SG8Cb

0

30

0

25

21

0

20

41

25

0

0

26

Klebsiella
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Figure 6.1: Phylogenetic tree constructed for partial 16S rRNA gene of bacterial
strains from Belostomatids
* Reference strains; GU126803.1| Klebsiella pneumonia, NR_029209.1| Burkholderia
cepacia, GQ292550.1| Proteus vulgaris
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Figure 6.2: Phylogenetic tree constructed for partial 16S rRNA gene of bacterial
strains from Naucorids
* Reference strains; GU126803.1| Klebsiella pneumonia, NR_029209.1| Burkholderia
cepacia, GQ292550.1| Proteus vulgaris
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Figure 6.3: Percentage of insects positive for each bacterial strains identified using
16S rRNA sequencing
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Figure 6.4: Percentage abundance of phylotypes within culturable isolates and 16S
rRNA gene library strains of bacteria in Belostomatids and Naucorids
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Concluding remarks
Buruli ulcer continues to remain a devastating disease in tropical rural parts of the
world especially Africa. Both the disease and the causative organism, Mycobacterium
ulcerans are of key interest to researchers because of the unusual patterns of the disease
pathology and the biology of the bacterium repectively. Unlike other infections with
environmental mycobacteria, the painless nature and slow progression of Buruli ulcer,
makes it so devastating. Affected individuals seek health care only at the late and
ulcerative stages of the disease. The stigma associated with the disease only goes to
further retard its reporting. On the part of the causative organism, the fact that its DNA
has been associated with many aquatic organisms, reveals a complex biology that makes
it difficult to determine in which particular organism M. ulcerans is replicating. The
hydrophobicity of the bacterium makes it concentrate at the air water interface in the
environment and makes it readily form biofilms of the surfaces of many organisms.
Researchers have attributed the re-emergence of Buruli ulcer to the overlapping
ecology of man and environmental mycobacteria. Man-made environmental disturbances,
particularly deforestastion, urbanization and sandwining as well as natural flooding that
occur due to rainfall patterns have been implicated as risk factors in the epidemiology of
the disease. Noteworthy in the transmission of the disease is that person-to-person
transfer of the bacterium is rare and that man becomes infected primarily through dierect
contact with the environment. This signifies the true environmental nature of M.
ulcerans, implying that it does not need the human host to proliferate in nature. The
hypothesis that trauma to the skin is necessary for the introduction of M. ulcerans to the
host hence bears significant validity. What remains to be addressed then is the
identification of the environmental reservoir of the bacterium and the potential vectors
that can cause injury to the skin and ultimately deliver an infective dose of M. ulcerans to
unsuspecting human hosts.
Advances in research identifying various aquatic organisms that are PCR positive
for M. ulcerans DNA suggests that the bacterium is being transferred within a complex
food web. This implies two possibilities; (i) that the bacterium has a high diversity of
metabolism, thus being able to proliferate in more than one organism, or (ii) that the
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bacterium is contained within a secondary organism such as a protozoan, which is also
associated with similar aquatic organisms as M. ulcerans. It is also important to note here
the ongoing reductive evolution of M. ulcerans from its ancestor M. marinum. This has
been characterized by significant genome contraction by the generation of pseudogenes
and DNA rearrangement leading to the loss of coding sequences that may have allowed
M. ulcerans to occupy similar niches as M. marinum. A good example is the truncation of
the crtB locus in M. ulcerans. In M. marinum, this locus is responsible for the production
of light induced carotenoids that protect the bacteria from direct sunlight (Stinear 2007).
The absence of a full gene product in M. ulcerans, makes the bacterium sensitive to light
indicating a change in its environmental niche. Other bacteria that have undergone
significant genome contraction and niche specialization include M. leprae, Yersinia pestis
and Bordetella pertusis (3).
The acquisition of the mycolactone producing plasmid is thought to have occurred
by lateral gene transfer (5), however, the specific role for the toxin in the environment
has not been elucidated. Is it possible that the toxin confers a selective advantage for
niche domination in the environment? Is the toxin synthesized by the bacterium in the
environment or only in the human host? Which phenomenon occurred fisrt; the genome
downsizing or the acquisition of the plasmid? Why are the other mycolactone producing
mycobacteria such as M. liflandii and M. pseudoshottsii associated with definite
environmental hosts and what is the evolutionary history between these strains and M.
ulcerans?
In the search for answers to the mode of transmission of M. ulcerans to man, it is
imperative to experimentally test the findings in nature in a laboratory setting. The work
presented in this study has sought to understand the role of insects and fish in
transmission. We have shown that due to the waxy nature of M. ulcerans, it readily forms
an extracellular matrix on the surface of Belostomatids, and hence can be directly
introduced to unsuspecting humans that are accidentally bitten. We do not have
conclusive evidence that the bacterium replicates within these insects but we cannot rule
out the possibility of them being involved in the transfer of the bacterium in nature. The
history with bacteria that are vectored primarily by insects involves a long evolutionary
process of co-adaptation, and most of the insects are haematophagous. This is not the
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case with Belostomatids or Naucorids; they are both predaceous. It is possible that
aquatic insects may play other roles in the transmission process and future studies should
specifically address the biology of the bacterium with respect to the biting insects.
We also show that fish may transiently contain M. ulcerans in the environment,
however, unlike most environmental mycobacteria, M. ulcerans does not cause disease in
fish (Japanese Medaka). Even though M. marinum DL and M. pseudoshottsii produce
mycolactone and cause disease in fish, M. ulcerans specifically only produces disease in
humans. Future studies should involve identifying whether M. ulcerans is pathogenic in
other types of fish such as zebra fish and gold fish because they might exhibit different
immune responses. We have also shown that mycolactone is cytotoxic to fish cells in
vitro. Although the precise molecular mechanism of mycolactone on eukaryotic cells is
unknown, it has been shown to accumulate in the cytosol eventually leading to cell cycle
arrest and apoptosis (4). The effects of mycolactone are also ubiquitous, and not cell
specific.
Despite the action of the toxin, the possibility of M. ulcerans living within
protozoans is a hypothesis worth testing. Other environmental mycobacteria have been
shown to replicate within Acanthamoeba (1). Recently, it was shown that mycobacteria
are capable of foming spores (2). This may contribute to the persistence of M. ulcerans in
the environment and also account for the dormancy and latency of the bacterium in
nature. Much work is yet to be done to specifically understand the mode of transmission
of M. ulcerans. This work is just a tip of the iceberg!
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